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1.1. The role of iron in biological systems 
 
Out of the more than 100 chemical elements known to scientists today, only a 
relatively small number of these elements are found in the human body. In fact, only 24 
different elements are thought to be essential for humans. The largest elemental 
components of the body, by mass, are oxygen (65%), carbon (18%), hydrogen (10%), and 
nitrogen (3%).
1
 The other elements present in the body are known to physiologists as trace 
elements. Some of the trace elements are metal ions like copper, zinc, iron and manganese 
which are vital to the body's proper functioning. They must be present at the proper level, 
and they must also be available to react with other elements to form the molecules in the 
functional state.  
Metals are involved in a wide range of biochemical processes in all living 
organisms. They are ’’key’’ players in electron transfer, oxygen transport and numerous 
catalytic reactions. The use of metals in living organisms is mainly related to red-ox 
reactions and to the ability to catalyze numerous essential functions such as hydrolysis. 
Metalloprotein is a generic term for a protein that contains a metal ion cofactor. Indeed, 
about one quarter to one third of all proteins require metals to carry out their functions.
2,3,4
 
The metal ion is usually coordinated by nitrogen, oxygen or sulfur atoms belonging 
to amino acids in the polypeptide chain and/or a macrocyclic ligand incorporated into the 
protein. The presence of the metal ion allows metalloproteins to perform functions that 
cannot efficiently be performed by the limited set of functional groups found in amino 
acids. Numerous proteins bind one or more metal ions which can be involved either in 
functional process or necessary to obtain/maintain the protein’s tertiary or quaternary 
structure or both. Also in the case of RNA metal ions are very important for function and 
structure. 
5,6
 
One of the most abundant essential trace elements in the human body is iron. 
Healthy adults possess from 4 to 6 g of iron, which approximately comprises only 0,008% 
of the body mass (75 kg).
7,8
 Nevertheless it is necessary for our survival. The bulk of this 
iron is bound to hemoglobin in the red blood cells, where it is necessary for oxygen 
transport in the blood. In humans, the hemoglobin molecule is an assembly of four globular 
protein subunits. Each subunit is composed of a protein chain tightly associated with a non-
protein heme group. Iron is the central atom of the heme group, a metal complex that binds 
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molecular oxygen (O2) in the lungs and carries it to all of the other cells in the body that 
need oxygen to perform their activities (e.g., muscle cells). In addition to hemoglobin, 
other important proteins in the body that contain heme groups (and therefore contain iron) 
include myoglobin, which takes oxygen from hemoglobin and allows the oxygen to diffuse 
throughout the muscle cells, and the cytochromes, which transfer electrons.
7,9 
Other class 
of iron bound proteins are those binding iron-sulfur clusters (Fig. 1). These 
proteins are characterized by the presence of iron-sulfur (Fe-S) clusters containing sulfide-
linked di-, tri-, and tetra-iron centers in variable oxidation states. Fe-S clusters are found in 
a variety of metalloproteins, such as the ferredoxins, as well as NADH dehydrogenase, 
hydrogenases, Coenzyme Q - cytochrome c reductase, succinate - coenzyme Q reductase 
and nitrogenase. Fe-S clusters are best known for their role in the oxidation-reduction 
reactions of mitochondrial electron transport. Both Complex I and Complex II of oxidative 
phosphorylation have multiple Fe-S clusters. They have many other functions including 
catalysis as illustrated by aconitase, generation of radicals as illustrated by SAM-dependent 
enzymes, and as sulfur donors in the biosynthesis of lipoic acid and biotin. Additionally 
some Fe-S proteins regulate gene expression. 
Figure 1. Examples of protein cofactors containing iron. 
Other proteins, such as those needed for DNA synthesis and cell division, also rely 
on iron. Furthermore, iron contributes to produce the connective tissues in our body, some 
of the neurotransmitters in our brain, and to maintain the immune system.  
While iron is necessary for allowing the respirating cells to obtain O2, for supplying 
the body with a reliable source of energy, and for maintaining several other important 
structures and systems in the body, yet its properties also make it potentially deleterious. 
The biological importance of iron is largely attributable to its chemical properties as a 
transition metal. It readily engages in one-electron oxidation-reduction reactions between 
its ferric (+3) and ferrous (+2) states. However, the same chemical property explains why  
  Introduction 
7 
 
an excess of ―free,‖ reactive iron is toxic. In the cytoplasm, a significant fraction of iron is 
reduced and can participate in ―Fenton-type‖ redox chemistry: ferrous iron reacts with 
hydrogen peroxide (H2O2) or lipid peroxides to generate ferric iron, OH
-
, and the highly 
reactive hydroxyl radical (OH•) or lipid radicals such as LO• and LOO•. These radicals 
damage lipid membranes, proteins, and nucleic acids.  
 
Fe
2+
 + H2O2 → Fe
3+
 + OH· + OH− 
Fe
3+
 + H2O2 → Fe
2+
 + OOH· + H+ 
 
To avoid the above harmful redox reactions, iron homeostasis is achieved through iron 
transport, storage and regulatory proteins. That allows the cells to use the benefits of iron, 
but also limits its ability to do harm.
10,11 
 
1.2. Iron metabolism and cellular uptake 
 
Iron uptake is tightly regulated by the human body, which do not have pathways for 
iron excretion. Only small amounts of iron are lost daily due to mucosal and skin epithelial 
cell sloughing, desquamation of skin and urinary cells, blood loss, or sweat. To compensate 
this loss only about 1-2 mg of dietary iron per day is absorbed by duodenal enterocytes. 
This amount of iron compared to the amount ingested is typically low. The efficiency with 
which iron is absorbed varies largely depending on the source and generally the best 
absorbed forms of iron come from products of animal origin.
8,12
 Duodenal enterocytes have 
special proteins that allow them to move iron into the body. Iron can be absorbed in its 
ferrous Fe
2+
 form. A ferric reductase enzyme on the enterocytes brush border, reduces 
ferric Fe
3+
 to ferrous Fe
2+
, and in this form iron is imported into enterocyte via divalent 
metal transporter 1 (DMT1). Iron is released directly into the blood stream by ferroportin 
which is located at the basolateral membrane of duodenal enterocytes. It is oxidized to the 
Fe
3+
 form and binds to transferrin (Tf). Tf-2Fe
3+
 complexes circulate in the plasma, and 
deliver iron to all the tissues. Most of the iron is incorporated into hemoglobin, in erythroid 
precursors and mature red blood cells (approx. 1800 mg). Approximately 400 mg is present 
  Introduction 
8 
 
in the other tissues (in enzymes and cytochromes) and muscle fibers (in myoglobin). Liver 
(parenchymal cells) and reticuloendothelial macrophages are responsible for iron storage 
(approx. 1600 mg). The macrophages provide most of the usable iron by degrading 
hemoglobin in aged or damaged erythrocytes and reloading ferric iron onto transferrin for 
delivery to cells, because the amount of plasma iron is just around 10% (approx. 3 mg) of 
the amount used daily, which means that plasma iron is turned over many times each day 
(Fig. 2). All cells use some iron, and must get it from the plasma. Since iron (in the ferric 
state) is tightly bound to transferrin (Tf), cells throughout the body have receptors (TfR1) 
for Tf-2Fe
3+
 complexes on their surfaces. These receptors engulf and form endosomes 
containing both the protein and the iron attached to it. A proton pump decreases the pH 
within the endosomes, leading to conformational changes in the transferin that result in the 
release of iron. The iron is reduced to the ferrous state and transported by DMT1 across the 
endosomal membrane, to enter the cytoplasm. Intracellular iron can be utilized for direct 
incorporation into iron proteins or delivered to mitochondria, where the iron-dependent 
step of heme synthesis and critical steps for Fe-S cluster biogenesis are localized. The 
fraction of the cytosolic iron that is not utilized for metalation reactions can be stored in 
ferritin in a nontoxic form or exported via ferroportin, which works together with 
ferroxidases for iron loading onto transferrin in plasma. Meanwhile, transferrin (Apo-Tf) 
and transferrin receptor are recycled to the cell surface, where each can be used for further 
cycles of iron binding and iron uptake.
5,10,13
 
 
 
 
 
 
 
 
 
Figure 2. Circulation of iron in human body. Reprinted from Hentze et al. Cell (2004).  
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Disruptions in iron homeostasis from both iron deficiency and overload account for 
some of the most common human diseases (e.g. hemoglobin and iron deficiency anemia or 
hemochromatosis). That is why cells developed mechanisms for sensing their own need of 
iron. Iron metabolism is maintained by two regulatory systems:  
  the first one functions systemically and relies on the hormone hepcidin that directly 
inhibits ferroportin. By inhibiting ferroportin, hepcidin prevents enterocytes of the 
intestine and macrophages of the reticuloendothelial system from secreting iron into 
the blood stream, thereby functionally reducing the iron level.  
 
  the second one  predominantly controls the cellular iron metabolism through iron-
regulatory proteins (IRP1 and IRP2). When the iron level in the cell is low IRPs bind 
to iron-responsive elements in regulated messenger RNAs of the transferrin receptors 
and ferritin. The binding of IRPs to iron responsive elements (IREs) in the 5’-
untranslated regions (UTRs) of mRNA blocks the translation (e.g. of ferritin), while 
IRP binding to the IRE in the 3’-UTR stabilizes the mRNA (e.g. of transferrin 
receptor). When the iron concentration in the cell is high IRP1 binds an [4Fe-4S] 
cluster (and acts like aconitase) and IRP2 degrades with the result that they can no 
longer bind to mRNA. This liberates the IRE in the 5’-untranslated region of Ferritin 
mRNA and directs the cell to produce more storage molecules. On the other hand the 
free IRE at the 3’-UTR of transferrin receptors accelerates its mRNA degradation 
resulting in decreased protein expression.
14,15
  
 
1.3. The role of iron in mitochondrial processes 
 
The mitochondrion is an eukaryotic cellular organelle that contains outer and inner 
membranes composed of phospholipid bilayers and proteins.
20
 Because of this double-
membraned organization, there are five distinct compartments within the mitochondrion 
(Fig. 3): 
 the outer mitochondrial membrane,  
 the intermembrane space (the space between the outer and inner membranes),  
 the inner mitochondrial membrane,  
 the crista space (formed by infoldings of the inner membrane),  
 and the matrix (space within the inner membrane). Main place for iron utilization. 
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Figure 3. Schematic representation of the mitochondrion structure. 
 
Mitochondria are well known for their role in ATP synthesis. The overall process of 
oxidizing glucose to carbon dioxide is known as cellular respiration. ATP can be produced 
via three main pathways: the glycolysis and the citric acid cycle/oxidative phosphorylation, 
both components of cellular respiration, and the beta-oxidation. The majority of this ATP 
production by a non-photosynthetic aerobic eukaryote takes place in the mitochondria, 
which can make up nearly 25% of the total volume of a typical cell. Iron is directly 
involved in the ATP synthesis, because its reversible oxidation states allow electron 
transfer processes that are necessary for respiratory chain via its heme and iron-sulfur 
clusters (ISCs) containing complexes. Additionally, the mitochondrion is also the main site 
of heme synthesis and a major generator of ISCs, both of which are present in 
mitochondria and cytosol. Moreover, the synthesis of ISCs is the only essential 
biosynthetic process performed by these organelles.
16,17,18,19
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1.4. The role and types of ISCs 
 
ISCs are ubiquitous protein cofactors highly conserved from bacteria to human. 
Practically, they play a crucial and essential role in every living cell. In the earliest forms 
of life, when the earth’s atmosphere was a reducing and anaerobic environment (few 
billion years ago), Fe-S cluster proteins were used to perform fundamental metabolic 
processes (amino acid metabolism). After transformation of the atmosphere into an 
oxidative and aerobic environment (which does not support the formation, neither the 
stability of ISCs) the organism evolved a whole set of proteins to coordinate a safe, 
efficient and specific ISC biogenesis. Another reason why biosynthesis of ISCs has to be 
strictly controlled is their potential toxicity. Improper biogenesis of the clusters may fuel 
the Fenton chemistry, which produces highly toxic reactive oxygen species (ROS).
19,21,22 
ISCs are indispensable for life because of the ability of the iron to accept or donate 
electrons, formally altering between the ferrous (Fe2+) and ferric (Fe3+) oxidation states. 
In fact Fe-S proteins have a wide range of reduction potentials (–700 mV to 400 mV) and 
are among the most important electron carriers in nature.
23
 They play a central role in three 
processes: respiration, photosynthesis and nitrogen fixation which are crucial for life on 
earth. Fe-S clusters might serve to transfer electrons, perform catalysis, stabilize three-
dimensional protein structures or have regulatory function. Enzymatic functions of Fe-S 
proteins include Lewis acid catalysis in aconitase-type proteins, DNA and RNA synthesis 
and repair, and iron and heme metabolism.
24
  
Fe-S clusters are formally composed of ferrous (Fe
2+
) and/or ferric (Fe
3+
) iron, and 
inorganic sulfide (S
2−
) ions. However a class of low-molecular-weight iron-containing 
proteins called rubredoxins, sometimes classified as iron-sulfur proteins, do not contain 
inorganic sulfide but coordinates iron ion by the sulfurs of four cysteine residues. With 
exception of rubredoxins, the most common Fe-S clusters present in living organisms are 
the [2Fe–2S] and [4Fe–4S] clusters (Fig. 4). [2Fe–2S] is the simplest polymetallic system 
constituted by two iron ions bridged by two sulfides. The cofactor is usually coordinated 
by four cysteine residues or two cysteines and two histidines (in Rieske proteins). The 
[2Fe–2S] cluster exists in two oxidation states; the oxidized proteins contain two Fe3+ ions, 
whereas the reduced proteins contain one Fe
3+
 and one Fe
2+
 ion.
25,26
 In [4Fe–4S] clusters 
four iron ions and four sulfide ions are placed at the vertices of a cubane-type structure. It 
is formed by the fusion of two [2Fe–2S] clusters. Proteins coordinating [4Fe–4S] clusters 
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can be subdivided in two groups; the low and high potential depending on the pair of the 
commonly accessible oxidation states. In high potential proteins the cluster shuttles 
between [2Fe
3+
, 2Fe
2+
] (Fe4S4
2+
) and [3Fe
3+
, Fe
2+
] (Fe4S4
3+
), whereas in low potential 
[Fe
3+
, 3Fe
2+
] (Fe4S4
+
) and [2Fe
3+
, 2Fe
2+
] (Fe4S4
2+
). The third type of cluster coordinated by 
proteins is the [3Fe–4S] cluster, where three sulfide ions bridge two iron ions each, while 
the fourth sulfide bridges three iron ions. Their formal oxidation states may vary from 
[Fe3S4]
+
 (all-Fe
3+
 form) to [Fe3S4]
2-
 (all-Fe
2+
 form). In a number of Fe-S proteins, the 
[Fe4S4] cluster can be reversibly converted by oxidation and loss of one iron ion to a 
[Fe3S4] cluster. For example the inactive form of aconitase possesses an [Fe3S4] and is 
activated by addition of Fe
2+
 and reductant.
21,22,23
 Despite the simple structure and easy 
incorporation of the cluster into purified apo-proteins in vitro, the mechanisms of cluster 
assembly in vivo requires dedicated machineries. 
                   
Figure 4. Schematic representation of [2Fe-2S] and [4Fe-4S] clusters. Iron and sulfur 
atoms are represented as red and yellow balls respectively.  
 
1.5.  Biogenesis of ISCs 
 
The biosynthesis of the Fe-S clusters raised quite interest in the past 
years.
27,28,29
 The most extensive studies were focused on bacteria (Escherichia 
coli and Azetobacter vinelandii ) and yeast Saccharomyces cerevisiae. Three different 
systems were identified for the biogenesis of bacterial Fe-S proteins: the NIF system, for 
specific maturation of nitrogenase in azototrophic bacteria; the ISC assembly and SUF 
systems, for the generation of housekeeping Fe-S proteins under normal and oxidative-
stress conditions, respectively. The yeast S. cerevisiae has served as an excellent model 
organism to establish the first details of the complex biosynthesis pathways in eukaryotes. 
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Recent investigations in human cell culture and other model systems have demonstrated 
that the entire process is highly conserved from yeast to human. 
Three distinct protein machineries are required in the (non-plant) eukaryotic cells 
for the biogenesis of the Fe-S clusters; the ISC assembly machinery in mitochondria 
(inherited from bacteria during evolution), the ISC export machinery located in the 
mitochondrial inter membrane space, and the cytosolic ISC assembly machinery 
(CIA)(Fig. 5). ISC export and CIA machineries are specifically involved in the maturation 
of cytosolic and nuclear ISC proteins, whereas the mitochondrial ISC assembly machinery 
is required for the generation of all cellular Fe-S proteins.
30,31,32
  
 
Figure 5. Schematic representation of ISC assembly in eukaryotic cell 
 
 
 
1.5.1. Mitochondrial ISC assembly machinery 
 
The overall biogenesis process in mitochondria can be split into two main steps: the 
de novo assembly of an Fe-S cluster on a scaffold protein, and the transfer of the Fe-S 
cluster from the scaffold to target apo-proteins. Each of these steps involves the 
participation of several proteins and cofactors, which execute specific biosynthetic partial 
reactions.
33
 Indeed over 15 proteins are known to play a role in this complicated 
biosynthetic process. The mitochondrial components required for Fe-S cluster formation in 
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higher organisms are similar to the bacterial ISC proteins and apparently were inherited 
from a prokaryotic progenitor.
34
  The central component of the mitochondrial ISC 
assembly machinery is the scaffold protein IscU on which de novo assembly of a Fe-S 
cluster takes place. IscU is one of the most conserved proteins in evolution and is found in 
many bacteria, and virtually all eukaryotes. It has three cysteine residues which are 
necessary for the cluster synthesis. Both [2Fe-2S] and [4Fe-4S] clusters can be assembled 
on IscU.
35,36,37
 To accomplish de novo cluster formation, sources of iron and sulfur are 
necessary. Iron is imported from the cytosol into mitochondria through the innermembrane 
transporters Mitoferrin1/2 (Mrfn1/2) in its ferrous (Fe
2+
) form, and is delivered to the 
scaffold by Frataxin which was shown to interact with IscU in vivo and in vitro in an iron 
stimulated fashion.
38,39,40
 The free cysteine is the source of the sulfur, the latter is released 
and delivered to IscU by the complex of cysteine desulfurase IscS-Isd11. A persulfide is 
formed on a conserved cysteine residue of the enzyme, and is then transferred to the 
scaffold protein. Although isolated IscS has the enzymatic activity (as a cysteine 
desulfurase) in vitro, the IscS–Isd11 complex is the functional entity for sulfur transfer 
from IscS to IscU in vivo.
41,42,
 This reaction is aided by direct interaction between IscS and 
IscU. Before the assembly reaction on IscU is accomplished the sulfur is reduced by the 
electron transfer chain composed of ferredoxin and ferredoxin reductase which receives the 
electron from NADH (Fig. 6). 
 
 
 
Figure 6.  First step of ISC biosynthesis process in mitochondria - assembly of  [Fe-S] 
cluster on ISCU. 
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The second major step performed by late components of the ISC assembly 
machinery is the release of the Fe-S cluster from IscU and its transfer and incorporation 
into recipient apo-proteins. The interaction of scaffold protein with co-chaperone HSCB 
and HSPA9 promotes the conformational changes of IscU and dislocates the cluster.
43
 
Afterwards the delivery of the assembled Fe-S cluster to the mitochondrial recipients is 
performed by a group of chaperones, e.g. Glutaredoxin5, IscA1/2, C1orf69 (specifically 
required for the gaining activity of aconitase-type and SAM-dependent Fe-S enzymes) or 
recently reported Ind1 (necessary for cluster incorporation into respiratory Complex I of 
oxidative phosphorylation in mitochondria).
44,45,46,47 
Mitochondrial and cytosolic Fe-S 
cluster protein maturation strictly depends on the function of the ISC machinery, which 
produces a still unidentified compound X that is later exported from mitochondria by the 
ISC export machinery and used for cytosolic Fe-S cluster formation (Fig. 7).  
 
Figure 7. Mitochondrial ISC assembly machinery components and pathway. 
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1.5.2. Mitochondrial ISC export machinery 
 
The necessity of mitochondrial ISC assembly for cytosolic Fe-S protein maturation 
was previously explained by the export of ready, preassembled clusters. This idea was 
abandoned when the ISC export system was discovered. The export machinery consists of 
three components; the inner mitochondrial membrane ABC transporter - ABCB7, the 
intermembrane space protein - ALR and three peptide glutathione – GSH (Fig. 8). 
Downregulation or depletion experiments of latter proteins in yeast and human cell lines 
lead to defective cytosolic and nucleus Fe-S proteins due to improper maturation and 
increased iron uptake in the cell and mitochondrial iron overload.
48,49
   It was shown in 
vitro that ATPase activity of the yeast homologue of ABCB7 (the yeast homologue is 
called Atm1) is stimulated by the sulfhydryl groups (e.g. cysteine residues).
50
    Because 
the ATPase of ABC transporters is usually stimulated by their physiological substrates, this 
may indicate that the substrate X transported from the mitochondria contains a sulfhydryl 
group in a peptidic environment. Moreover, a further step of the export process is 
performed by the ALR, which has sulfhydryl oxidase activity and is located in the 
mitochondrial intermembrane space. ALR has also been shown to assist incorporation of 
disulfide bonds by Mia40 into substrate proteins during protein import and trapping in the 
IMS.
51,52,53
  The last component of the ISC export machinery – GSH is a reducing agent, 
existing at a concentration of approximately 10 mM in animal cells. In summary, all 
known components of the ISC export machinery deal with sulfhydryl chemistry, but 
identification of their specific function will depend on the identification of the exported 
moiety.
19,26
 
 
Figure 8. Mitochondrial ISC export machinery. 
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1.5.3. CIA - cytosolic iron-sulfur cluster assembly 
machinery  
 
The maturation of cytosolic and nucleus Fe-S proteins requires not only the 
functionality of the mitochondrial ISC assembly machinery but also a dedicated 
cytoplasmic system (CIA). The overall process can be subdivided into two steps; first the 
cluster is assembled on scaffold proteins and later transferred to apo-proteins (Fig. 9).  Till 
date six proteins were identified to play a crucial role in this process;  
 NUBP2 and NUBP1 (both P-loop NTPases) that form a hetero complex 
where de novo cluster formation takes place,  
 IOP1 required for cluster transfer to the apo-proteins, 
 CIAO1 that mediates protein-protein interaction between NUBP1 and IOP1,  
 CIAPIN1 (also called anamorsin) whose yeast homologue Dre2 was shown 
to be partially localized in the mitochondrial intermembrane space,  
 and Ndor1 that was shown to transfer electrons from NADH to the Fe-S 
cluster of anamorsin.
22,26,48,54,55,56
 
 
 
 
Figure 9. Components of cytosolic ISC assembly machinery. 
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Interestingly, the incorporation of anamorsin’s Fe-S cluster is independent from the 
CIA machinery. Considering anamorsin’s double localization, and it’s CIA-independent 
Fe-S assembly, this protein can link the mitochondrial and the cytosolic assembly 
machineries.  
All the components of the CIA machinery are defined by having a primary location 
in the cytoplasm and they act just in the cytosolic (not the mitochondrial) Fe-S cluster 
protein maturation. This distinguishes CIA proteins from ISC factors that are important for 
both mitochondrial and cytosolic Fe-S cluster biogenesis and ISC export proteins that are 
required for cytosolic cluster biogenesis but are located only within the mitochondria. The 
cytosolic Fe-S maturation machinery is functionally conserved from yeast to humans. 
Complementation tests performed on yeast strains depleted for the Cia1 and Dre2 
(homologues of CIAO1 and Anamorsin, respectively) showed that human proteins can 
functionally replace them in vivo. Depletion experiments of single CIA factors in yeast and 
human cell lines lead to a massive reduction in growth rates, malfunction of iron 
homeostasis (impaired maturation of IRP1) and decrease of cytosolic Fe-S protein 
activities, with preserved activity of mitochondrial Fe-S proteins. This suggests that the 
cytosolic ISC assembly system works downstream of the ISC assembly machinery in 
mitochondria.
57,58
 Identification of factor X, necessary for cytosolic cluster formation, 
produced by the ISC assembly machinery and exported by the ISC export machinery will 
give a new insight into the overall cellular maturation process, and will help to fully 
understand the connection between these three distinct machineries.  
 
1.6 Biogenesis of ISC and human diseases  
 
 Fe-S clusters are essential cofactors of many proteins and the disruption of their 
biosynthesis leads to dysfunction of many fundamental cellular processes. Indeed the 
mutations in numerous genes encoding the members of ISC and CIA biogenesis pathways 
were connected with human diseases. The two classical examples of Fe-S protein-linked 
diseases are Friedreich’s ataxia (FRDA) and X-Linked Sideroblastic Anemia and Ataxia 
(XLSA/A). The first one described was FRDA, which is the most common autosomal 
recessive ataxia, affecting about 1 person in 50,000.
59,60  
The disease is caused by mutations 
in the gene encoding Frataxin, a protein that is essential for ISC biogenesis in 
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mitochondria. In most cases, the mutant gene contains expanded GAA triplet repeats in the 
first intron which causes the gene silencing.
61
 Patients show signs of mitochondrial Fe-S 
protein defects (e.g. complexes I–III of the respiratory chain and aconitase) and accumulate 
iron in the heart and neuronal tissues. These cause progressive damage to the nervous 
system resulting in symptoms ranging from gait disturbance and speech problems to heart 
malfunction, decreased life span, and tumor growth.
62,63 
XLSA/A is caused by mutations in 
the human gene encoding the ATP-binding cassette of the ISC export machinery - 
ABCB7.
64
 The phenotype developed by ABCB7 gene inactivation in man represents Fe-S 
protein defects in the cytosol (but not in mitochondria), heme defects and iron 
accumulation in mitochondria that forms so-called ring sideroblasts (i.e., iron-loaded ring-
shaped tubules, which are concentrated around the nucleus).
65,66
 The illness is rare, and 
only few patient families have been described. Recently, several other diseases have been 
connected with defects in ISC assembly. A malfunction of the human mitochondrial 
monothiol glutaredoxin5 (Glrx5) was found in a patient who had microcytic anemia. In 
GLRX5-deficient cells, ISC biosynthesis was impaired which lead to high activity of IRP1, 
increased levels of IRP2, cytosolic iron depletion, and mitochondrial iron overload.
67
 A 
myopathy with exercise intolerance, intracellular iron overload, and deficiencies in 
succinate dehydrogenase and aconitase activity were connected with the splicing mutation 
in the gene encoding the central component of the ISC assembly machinery in 
mitochondria – the scaffold protein IscU.68  
Figure 10. Cellular processes affected upon malfunction of mitochondrial and cytosolic 
ISC biogenesis. Reprinted from Rouault et al., Trends Genet (2008).  
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In summary, the disruption in cellular ISC biogenesis lead to malfunction of 
essential processes, e.g. TCA cycle, energy production, heme biosynthesis, cellular iron 
homeostasis, DNA repair or glycolysis (fig.). 
69,70
 Syndromes of the connected diseases can 
appear in the central nervous system and heart (FRDA), in developing red blood cells 
(GLRX5 deficiency) or in skeletal muscles (myopathy with deficiencies in IscU). Iron-
sulfur clusters are cofactors of many proteins that play crucial roles in essential metabolic 
pathways common to all tissues. The fact that their dysfunction can cause such diverse 
disease presentations makes it very probable that mutations in other conserved Fe-S cluster 
biogenesis components lead to diseases for which the cause is presently unknown.
25
  
 
1.7 Wilson and Menkes – diseases linked with copper 
homeostasis 
 
Copper (as iron) is an essential element that participates in biological processes in 
eukaryotic and prokaryotic cells, because of its ability to change the redox state from Cu
+
 
to Cu
2+
. However the copper homeostasis has to be strictly controlled, because of copper 
potential toxicity.
71
 Indeed, excessive tissue accumulation of redox-active transition 
metals, as copper, result in an array of cellular disturbances characterized by oxidative 
stress and increased free radical production. Alterations of copper homeostasis lead to 
errors of metabolism and damage to cells, resulting in pathological conditions.
72
 Central 
regulators of cellular copper metabolism are two homologues copper-transporting P-type 
ATPases ATP7A (MNK) and ATP7B (WLN).
73,74 
The proteins differ in their tissue 
distribution of expression: WLN is predominantly expressed in the liver  and is responsible 
for delivery of Cu to ceruloplasmin (the main plasma form of Cu) and biliary efflux of Cu, 
whereas MNK is present in most non-hepatic tissue, especially skeletal muscle, fibroblast 
and brain.
75,76
   MNK has two important cellular functions:  to facilitate the export of 
copper from non-hepatic tissues, its absorption into circulation, and to deliver copper to the 
secretory pathway for incorporation in copper-dependent enzymes such as lysyl oxidase.
77
 
Both ATP7A and ATP7B are integral membrane proteins, respectively of 1500 and 1476 
amino acids, with various soluble domains. The Wilson protein has 67% amino acid 
identity to the Menkes protein
78
 and the same structural characteristics; six soluble metal  
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binding domains, and the core unit composed of eight transmembrane helices and two 
soluble domains, the Actuator-domain (A) and the ATP-binding domain. The latter one is 
composed by two sub-domains: the Nucleotide-domain (N) and the Phosphorylation-
domain (P) (Fig. 11).
79,80
 
 
 
Figure 11. Schematic representation of WLN and MNK proteins. Reprinted from Tumer et 
al., Eur J Hum Genet (2010) 
 
Mutations in ATP7A or ATP7B genes disrupt the homeostatic copper balance, 
resulting in copper deficiency (Menkes disease) or copper overload (Wilson disease), 
respectively.
81
 Menkes disease is a fatal X-linked copper deficiency disorder; affected 
individuals die in early childhood and have multiple abnormalities that can be related to 
deficiencies in cuproenzymes. Differently in the Wilson disease very high concentrations 
of copper are accumulated in the liver because the biliary excretion of the metal ion is 
defective. If this disease is not treated, death can result from liver failure.
79,82
 The overall 
view of copper uptake, efflux and distribution in various tissues is shown in Fig. 12. 
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Figure 12. Pathway of copper in the body, and the blocks in Menkes and Wilson diseases. 
Reprinted from Mercer, TRENDS in Molecular Medicine (2001).  
 
1.8 Aims and topics of the research 
 
During the three years of my PhD course my research was focused on expression, 
purification, biochemical and structural characterization of recombinant human proteins 
involved in iron-sulfur cluster biogenesis and copper homeostasis. A multidisciplinary 
approach integrating several biophysical techniques has been used.  
Several target proteins involved in ISC assembly in the cytosol and the 
mitochondria were chosen in order to understand at the molecular level their functional 
role in the pathways responsible for the Fe-S cluster incorporation in iron-sulfur dependent 
enzymes.  
1. The cytokine-induced anti-apoptotic molecule (CIAPIN1) had been found to be a 
differentially-expressed gene involved in a variety of cancers, and it was also considered as 
a candidate tumor suppressor gene in gastric, renal and liver cancer. Owing to its 
prognostic value for human tumors and its involvement in cancer progression and tumor 
cell resistance to anticancer agents, CIAPIN1 has been proposed as an attractive target for 
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new anticancer interventions.
83,84,85
 Recently its yeast homologue called Dre2 was reported 
to be a member of the cytosolic iron-sulfur cluster assembly machinery, and was found 
both in the cytosol and the mitochondrial intermembrane space. Moreover CIAPIN1 was 
able to substitute Dre2 in vivo.
54
 My work in this project was devoted to the structural 
characterization of CIAPIN1, and the characterization of its ISC-binding properties as well 
as its interaction with the potential physiological partner Mia40, which is responsible for 
protein entrapment in the IMS. Full length protein and several constructs were cloned, 
expressed and purified. These proteins were characterized by NMR, EPR and mass 
spectroscopy techniques in order to give new hints on the function of this extremely 
important molecule in the iron-sulfur cluster biogenesis process. 
2. Glutaredoxins (GRX) are redox proteins which use glutathione as a cofactor. 
They are divided into two classes, monothiol and dithiol and in each class, several GRX 
have been shown to form [2Fe-2S] cluster-coordinating homodimers or homotetramers. 
Glutaredoxin 5 is a monothiol glutaredoxin and was found to play a crucial role in the ISC 
assembly process in mitochondria. Absence of GRLX5 causes iron accumulation in the 
cell, which in turn could promote oxidative damage, and inactivation of enzymes requiring 
Fe-S clusters for their activities.
44
 The protein was recombinantly expressed in E.coli, 
purified and Fe-S cluster binding properties were characterized. Using 
1
H-paramagnetic 
NMR and UV-visible spectroscopy we indeed observed the binding of a [2Fe-2S] cluster.  
Interestingly, our NMR relaxation data showed that the cofactor is bound by the 
monomeric protein, at variance with what has been found in the crystal structure of holo- 
GLRX5. This result suggests that this monomeric form is the physiological one acting in 
the mitochondrial matrix. GLRX5 is indeed proposed to be involved in Fe-S cluster 
delivery to ISCA1 and ISCA2 protein partners. The monomeric form can more easily be 
the active state in the transfer process with respect to the tetramer in which Fe-S cluster is 
buried between the subunits. Protein-protein interactions and Fe-S cluster transfer between 
this monomeric form of holo-GLRX5 and apo- ISCA1 and ISCA2 are now in progress.  
3. The project that I was involved in at the beginning of my PhD course was 
devoted to the Menkes and Wilson proteins, which play essential roles in the copper 
homeostasis in the human body. Within the frame of this major project at CERM, where 
several domains of both the Menkes (MNK) and Wilson (WLN) protein were produced 
and characterized in terms of their structural and functional properties. I have attempted the 
production of the ATP-domains of both proteins and the P-domain of the MNK protein 
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with the final goal of understanding the molecular interactions between these soluble 
domains and other previously characterized domains that drives the copper pumping 
machinery.  
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2.1. Genome browsing  
 
One of the main challenges facing the molecular biology community today is 
to make sense of the wealth of data that has been produced by the genome sequencing 
projects. In the past decade, bioinformatics have become an integral part of research and 
development in the biomedical sciences. Bioinformatics now has an essential role both in 
deciphering genomic, transcriptomic and proteomic data, generated by high-throughput 
experimental technologies, and in organizing information gathered from traditional 
biology. It is an interdisciplinary research area at the interface between the biological and 
computational science. The ultimate goal of bioinformatics is to uncover the biological 
information hidden in the mass of data and obtain a clearer insight into the fundamental 
biology of organisms.  
Genome browsing is the first and crucial step for the expression and 
characterization of a recombinant protein. In this step, bioinformatic tools are necessary to 
analyse the nucleotide and amino acid sequences and obtain information useful for the 
choice of the protein target. A number of data banks are available and provide the scientific 
community tools for searching gene banks, for the analysis of protein sequences, for the 
prediction of a variety of protein properties. Primary databases contain information and 
annotations of DNA and protein sequences, DNA and protein structures and protein 
expression profiles. 
Some available databases for genome browsing are: 
 NCBI (www.ncbi.nlm.nih.gov/Entrez/) - This web site integrates information from 
several databases (Swissprot, EMBL, all geneBank, etc...) 
 PDB (www.rcsb.org/pdb) - A 3-D biological macromolecular structure database 
 Pfam (http://pfam.sanger.ac.uk/) - A collection of different protein families organized 
in terms of different domains as obtained from multiple alignments.
1
 
Secondary or derived databases are so called because they contain the results of 
analysis of the primary resource including information on sequence patterns or motifs, 
variants and mutations and evolutionary relationships.  
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Once all biological data is stored, the requirement is to provide bioinformatic 
tools for extracting the meaningful information. The most used programs for genome 
browsing are: 
 BLAST (www.ncbi.nlm.nih.gov/BLAST/): Standard BLAST (Basic Local Alignment 
Search Tool) is a set of similarity search programs designed to explore all of the 
available sequence databases regardless of whether the query is protein or DNA. 
PHIBLAST is designed to search for proteins that contain a pattern specified by the 
user, and simultaneously are similar to the query sequence. 
 CLUSTALW (www.ebi.ac.uk/clustalw/) is a general purpose multiple sequence 
alignment program for DNA or proteins. It produces biologically meaningful multiple 
sequence alignments of divergent sequences. It calculates the best match for the 
selected sequences, and lines them up so that the identities, similarities and differences 
can be seen. Evolutionary relationships can be seen via viewing Cladograms or 
Phylograms 
 PROSITE (www.expasy.org/prosite/) SCANPROSITE allows to scan a protein 
sequence, provided by the user, for the occurrence of patterns and profiles stored in the 
PROSITE database, or to search in protein databases all sequences with a user entered 
pattern. 
 STRING (http://string.embl.de/) STRING is a database of predicted functional 
associations among genes/proteins. Genes of similar function tend to be maintained in 
close neighbourhood and tend to be present or absent together.
2
 
 
2.2. Construct design 
 
Once the target protein is chosen, it is subjected to further bioinformatics 
investigations in order to predict important features like stability, solubility, 
hydrophobicity, secondary and tertiary structures. In this crucial step other bioinformatic 
tools can be used. 
 Several tools can be used in order to predict if the target is a fully soluble, 
transmembrane protein, or a protein containing both soluble and transmembrane 
domains;  
http://www.sbc.su.se/~miklos/DAS/, 
http://www.cbs.dtu.dk/services/TMHMM-2.0/, 
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http://www.ch.embnet.org/software/TMPRED/form.html; 
 The presence in the sequence of subcellular targeting signals can be confirmed by the 
tools from servers like: SignalP, TargetP and PSORT.org;
3,4,5
 
http://www.cbs.dtu.dk/services/TargetP/, 
http://www.cbs.dtu.dk/services/SignalP/, 
http://www.psort.org/; 
 Topological and structural predictions can help in the identification of intrinsically 
unstructured regions and the prediction of secondary and tertiary structures; 
6,7,8,9
  
http://iupred.enzim.hu/,  
http://bip.weizmann.ac.il/fldbin/findex/, 
http://www.sbg.bio.ic.ac.uk/~3dpssm/, 
http://pbil.univ-lyon1.fr/; 
 The construct should be designed with respect to the N-end rules;10 
These tools applied for each target protein, domain or construct selected for 
expression, can increase the probability of obtaining a soluble and well-folded protein. 
 
2.3. Gene cloning  
 
In order to get high yield of soluble proteins, many factors have to be taken in 
consideration, such as the choice of the vector, of the cloning strategy, and of culture 
conditions. Of course, the knowledge of the protein characteristics will help in this choice, 
thus increasing the chance of success. In the last years several eukaryotic expression 
systems were optimized, such as mammalian, yeast and insect cell expression. Cell-free 
protein synthesis has also a great potential, in particular with membrane proteins. 
11,12,13
 
However, especially for NMR which requires high yields of labelled 
15
N,
13
C and 
2
H 
samples, the E.coli expression system is nowadays the most widely used. That is why 
many efforts were focused on the optimization of this expression system. Gene fusion 
technology can facilitate purification, enhance protein expression and solubility, chaperone 
proper folding, reduce protein degradation, and in some cases, generate proteins with a 
native N-terminus. Factors such as reduced temperature, changes in the E.coli expression 
strain, different promoters or induction conditions and co-expression of molecular 
chaperones and folding modulators have all been examined and, in some specific cases, 
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they lead to enhancements of soluble protein production. Nevertheless, protein expression 
remains an arduous task that involves a complex decision tree. To date, no technology or 
reagent is a panacea. Thus, establishing tools and optimal conditions for each protein 
remains an empirical exercise.
14
 The best way to maximize the probability of obtaining a 
soluble and correctly folded target protein is to proceed with a parallel cloning and 
expression of it with a high number of fusion partners. Classical cloning, using restriction 
enzymes, typically cannot be adapted to high-throughput approaches, due to the 
complication of selecting compatible and appropriate restriction enzymes for each cloning 
procedure and to its multistep process. High-throughput cloning therefore requires 
procedures which can help to screen a broad range of conditions in less time, for these 
reasons new cloning technologies have been developed in recent years. Landy and 
coworkers have described a universal cloning method (Gateway technology) based on the 
site-specific recombination of bacteriophage lambda, which facilitates the integration of 
lambda into E.coli chromosome and the switch between the lytic and lysogenic cycle. 
15
 By 
this technology (developed by Invitrogen) it is possible to clone a target gene into different 
expression vectors eliminating the time consuming work with restriction enzymes and 
ligase (Fig. 1).  
 
Figure 1. Gateway technology allows one-step cloning in the pENTR vector, and by site-
specific recombination the target gene can be inserted in different expression vectors. 
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The entry vector is obtained via recombination reaction of the pENTR/TOPO vector with 
our gene (PCR fragment); the reaction is catalyzed by the Topoisomerase I. After isolation 
of the entry vector, the second step is to generate an expression construct by performing an 
LR recombination reaction between the entry clone and a Gateway destination vector of 
choice. This cloning method is faster due to the higher reaction efficiency and to the fact 
that only sequencing of the entry clone is required, and most of all, the destination vector 
are compatible with one single entry clone making the parallel approach easier. Moreover, 
using different destination vectors allows expressing a chosen protein with different 
fusions or tags, which can increase solubility, yield and make the purification of the target 
much easier. However, the main function of an expression vector is to yield the product of 
a gene (usually the more product the better).  Therefore, expression vectors are ordinarily 
equipped with very strong promoters; the rationale is that the more mRNA that is 
produced, the more protein product will be made. The ideal promoter is strong, has a low 
basal expression level, is easy to induce and is independent from the common components 
of culturing media. The most used promoter system for the bacterial expression of 
recombinant proteins is the T7/lac promoter.
16
 Genes under the control of T7/lac promoter 
can be transcribed by T7 RNA polymerase, in presence of lactose. Since E.coli cells do not 
produce this type of RNA polymerase, in order to use this promoter system they have to be 
genetically modified by incorporation of the genes encoding the T7 RNA polymerase, the 
lac promoter and the lac operator into their genome. The repressor is displaced from the lac 
operator when lactose or a similar molecule like Isopropyl β-D-1-thiogalactopyranoside 
(IPTG), is added to the culture. IPTG activates genes encoding the T7 RNA polymerase 
and the target protein in the plasmid, because lac operators are located upstream in the 
bacterial genome. Because of the high selectivity of the T7 RNA polymerase, almost all of 
the cell’s resources are converted to target gene expression and the amount of desired 
product can reach up to 50% of the total cell protein in few hours after induction. In some 
cases (e.g. toxic or membrane proteins) the basal expression of the recombinant protein has 
to be reduced. In order to achieve this, host strains containing the pLysS or pLysE vectors 
that express T7 lysozyme (natural inhibitor of T7 RNA polymerase) should be used. 
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2.4. Protein expression 
 
After bio-informatic characterization and choice of the cloning strategy several 
conditions for the target protein expression have to be tested in order to obtain a high yield 
of soluble protein. The variables which affect the expression of a recombinant protein are: 
host strain, growth medium and induction parameters (temperature, IPTG concentration 
and duration of induction step). A preliminary expression test is performed in a small-
volume scale using at least:  
 three different E.coli strains (e.g.: Bl21(DE3)pLysS a protease deficient strain, 
Rosetta(DE3) for rare codons containing genes and Origami(DE3) for disulphide 
containing proteins); 
 three different expression vectors (containing different tags and/or fusion partners); 
 three expression temperatures (37-25-17°C);  
 three inducer (IPTG) concentrations and different induction times (4-6-16h). 
Expression results are checked on SDS polyacrylamide gels (SDS-PAGE). This kind of 
approach allows to explore a large set of expression conditions and to evaluate which one 
gives the best yield of soluble protein. A second expression test is sometimes performed to 
better refine the expression conditions before the scale-up. On the basis of these 
preliminary results, the expression protocol can be optimised and, in case of negative 
results, it is possible to try the expression of mutants, change the cloning strategy, the 
construct or the expression system. With such an approach it is possible to find good 
expression conditions for many proteins. Anyway some proteins can be difficult to obtain,   
since E.coli is a prokaryote and lacks intracellular organelles, such as the endoplasmic 
reticulum and the Golgi apparatus, which are responsible for post-translation modifications 
of the produced proteins.   
 In case of negative results, variables like bacterial strain, induction time, the kind of 
vectors and expression promoters can be modified. If the main fraction of the protein is 
produced in the insoluble fraction, another approach is to try an in vitro refolding screening 
with different additives in order to get a folded and soluble protein. The last choices are to 
redesign the expressed domains or to switch to other expression system.
17
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 In dependence of the spectroscopic technique of choice, protein expression is 
performed in differently composed media. In fact, when large amounts of proteins must be 
isolated for techniques that do not require isotopic labelling, the culture is usually 
performed in a so-called rich or complex medium. Complex media contain water soluble 
extracts of plant or animal tissue (e.g., enzymatically digested animal proteins such as 
peptone and tryptone), and for this reason are rich in nutrients and minerals, assuring a fast 
bacterial growth and a high expression level. Their exact composition is unknown and this 
can impair the reproducibility of cultures. Chemically defined (or minimal) media are 
composed of pure ingredients in measured concentrations, dissolved in milliQ water; in 
this way the exact chemical composition of the medium is known, allowing high 
reproducibility of protein yields and grade and type of interferents. Typically, this class of 
media is composed of a buffering agent to maintain culture pH around physiological 
values, a carbon and energy source like a simple sugar (glucose) or glycerol, and an 
inorganic nitrogen source, usually an ammonium inorganic salt. In dependence of the 
bacterial strain and of the expressed proteins various mineral salts can be added and, if 
necessary, growth factors such as purified amino acids, vitamins, purines and pyrimidines. 
Chemically defined media are easier to isotopically enrich, simply using 
15
N and 
13
C 
enriched nitrogen and carbon sources in its composition, even if isotopically enriched 
complex media are also commercially available. 
 
2.5. Protein purification 
 
Basically, protein purification is a series of processes intended to isolate a single 
type of protein from a complex mixture. Protein purification is vital for the characterization 
of the function, structure and interactions of the protein of interest. Separation of one 
protein from all others is typically the most laborious aspect of protein purification. 
Separation steps exploit differences in protein size, physico-chemical properties and 
binding affinity. 
The location of expressed protein within the host will affect the choice of methods 
for its isolation and purification. Bacterial host may secrete the protein into the growth 
media, transport it to the periplasmic space, express a cytosolic protein or store it as  
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insoluble inclusion bodies within the cytoplasm. For insoluble proteins, the first 
purification step is the extraction from inclusion bodies. Indeed, most of the bacterial 
proteins are removed by different extraction steps with native buffer conditions, while the 
recombinant protein is extracted from inclusion bodies with a denaturing buffer.  
One of the most popular techniques of purification, which can be adopted for 
denatured and native state proteins, is immobilized metal ion affinity chromatography 
(IMAC). It is based on the specific coordinate covalent bond of amino acids, particularly 
histidine, to metals. This common technique involves engineering the sequence in such a 
way that 6 to 12 histidines are added to the N- or C-terminus of the protein. The 
polyhistidine binds strongly to divalent metal ions such as nickel. The protein can be 
passed through a column containing immobilized nickel ions, which binds the 
polyhistidine tag. All untagged proteins pass through the column. The protein can be eluted 
with imidazole, which competes with the polyhistidine tag for binding to the column, or by 
a decrease in pH (typically to 4.5), which decreases the affinity of the tag for the resin 
(Fig. 2).  
 
Figure 2. General purification procedure of a typical His-tagged proteins  
 ( Reprinted from Qiagen handbook for expression and purification of His-tagged proteins) 
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After the affinity purification, the fusion-tag must be removed from the 
recombinant protein. Indeed many expression vectors are engineered to express a protease 
clevage site between the fusion-tag and the protein. Tobacco Etch Virus (TEV), Factor Xa, 
Thrombin, Prescission Protease, recombinant Enterokinase are some examples of proteases 
that are normally used for the cleavage of tags. A second IMAC is generally performed in 
order to separate the fusion from the target native protein. However, if the fused protein is 
expressed in inclusion bodies, it must be refolded before performing the tag cleavage. This 
is not always possible, since fusion tags may interfere with protein folding.  
Gel filtration (GF) chromatography is the most common used purification step if 
the protein after affinity chromatography is not pure enough. GF is the simplest and 
mildest of all the chromatographic techniques; the support for gel filtration 
chromatography is composed of beads which contain holes, called "pores," of given sizes. 
Larger molecules, which can't penetrate the pores, move around the beads and migrate 
through the spaces which separate the beads faster than the smaller molecules, which may 
penetrate the pores. Size exclusion can be performed on a ―rough‖ level, separating the 
components of a sample in major groups to remove for example high or low molecular 
weight contaminants or to exchange buffers, while high resolution fractionation of bio- 
molecules allows to isolate one or more components of a protein mixture, to separate 
monomers from aggregates and last but not least to determine molecular weights or to 
perform a molecular weight distribution analysis, provided that suitable standards are 
available. 
  
2.6. Protein refolding 
 
Heterologous expression of foreign genes in E. coli often leads to production of the 
expressed proteins in IBs. IBs must then be solubilized and refolded into an active 
conformation. Refolding of IBs is not a straightforward process, often requiring an 
extensive trial-and-error approach. There are two important issues in recovering active 
proteins from IBs, i.e., solubilization and refolding. Solubilization must result in 
monomolecular dispersion and minimum non-native intra- or inter-chain interactions. 
Choice of solubilizing agents, e.g., urea, guanidine HCl, or detergents, plays a key role in 
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solubilization efficiency, in the structure of the proteins in denatured state, and in 
subsequent refolding.
18,19
  
Refolding is initiated by reducing concentration of denaturant used to solubilize 
IBs. Protein refolding is not a single reaction and competes with other reactions, such as 
misfolding and aggregation, leading to inactive proteins. Rate of refolding and other 
reactions is determined both by the procedure to reduce denaturant concentration and the 
solvent condition. The procedures to reduce the denaturant will be shortly described below: 
 One-step dialysis: Denatured, unfolded protein samples in concentrated denaturant 
solution are dialyzed against a refolding buffer, and hence, exposed to descending 
concentration of the denaturant.  
 Step-wise dialysis: This protocol uses descending concentration of denaturant for 
dialysis and has been successfully used for refolding antibodies. Unfolded protein 
sample is initially brought to equilibrium with high denaturant concentration, then with 
middle concentration, and with low concentration.  
 Buffer-exchange by gel filtration: Gel filtration column is equilibrated with the final 
refolding buffer. Unfolded protein sample in denaturant is applied to the column and 
run through it with the refolding buffer. Use of desalting column will separate proteins 
from denaturant, while use of protein-sizing column will fractionate protein species.  
 Dilution: Protein samples at high denaturant concentration are delivered into a large 
volume of refolding buffer. Dilution brings the unfolded sample into a rapid collapse, 
whereby bypassing the intermediate denaturant concentration.  
 Solid phase refolding: Denatured protein is initially non-covalently bound to solid   
matrix such as Ni-resin or ion-exchange resin in the presence of denaturant. Denaturant 
concentration is then decreased to initiate refolding. Since protein molecules are bound 
to resin, this procedure minimizes aggregation of unfolded protein or folding 
intermediates.  
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2.7. Protein characterization 
2.7.1. Metals content determination by ICP 
 
Inductively Coupled Plasma (ICP) is an analytical technique used for the detection of 
trace metals and allows multi-elemental, simultaneous analysis of most elements in the 
periodic table, with excellent sensitivity (ng/l or ppt) and high sample throughput. The 
analytical principle used is optical emission spectroscopy, triggered by plasma ionization. 
The liquid sample is introduced in the pre-chamber, usually by means of a peristaltic 
pump, then nebulized and entrained in the flow of plasma support gas, which is typically 
Argon. The analytes are excited into a state of radiated light emission by the plasma vapour 
and the emitted radiation is converted to an electrical signal that can be measured 
quantitatively by resolving the light into its component radiation (almost always by means 
of a diffraction grating). The light intensity is measured, at the specific wavelength for 
each element line, with a CCD (charge coupled device, basically an array of tiny, light-
sensitive diodes) which converts it to electrical signals. The electron signal intensity is then 
compared to previously measured intensities of standard solutions of the target elements, 
and a concentration is computed. This spectroscopic technique is very suitable for the 
protein’s metal content determination, since it requires very small amounts of sample, and 
is not perturbed by the polypeptidic matrix. 
 
2.6.2. Electron Paramagnetic Resonance 
 
Electron paramagnetic resonance (EPR) or electron spin resonance (ESR) spectroscopy 
is a technique for studying chemical species that have one or more unpaired electrons, such 
as organic and inorganic free radicals or inorganic complexes possessing a transition metal 
ion. The basic physical concepts of EPR are analogous to those of nuclear magnetic 
resonance (NMR), but electron spins are excited instead of spins of atomic nuclei. Because 
most stable molecules have all their electrons paired, the EPR technique is less widely used 
than NMR. However, this limitation to paramagnetic species also means that the EPR 
technique is of great specificity, since ordinary chemical solvents and matrices do not give 
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rise to EPR spectra. In a typical experiment the sample is placed in a resonant cavity which 
has a high quality factor Q (high Q leads to high sensitivity of the EPR method). At a fixed 
microwave frequency, the magnetic field Bo is varied until resonance occurs at the value Be 
given by 
Be = hv = g Bo  
In this equation g is the "g­factor" of the unpaired electron and  is the unit magnetic 
moment of the spinning electron (Bohr magneton). Free radicals have values that are fairly 
close to g = 2.0023 which characterizes a free electron, while some transition ions, such as 
cobalt (Co
2+
) and copper (Cu
2+), have g­values which differ significantly form that 
theoretical value.  
The resonant absorption is not infinitely narrow, since unpaired electrons do not only 
interact with the externally applied magnetic field, but also with the magnetic fields in their 
neighbourhood. By observing spectral line width and intensity, it is possible to obtain 
information about the spin environment. Electron spin exchange between identical and 
non­identical molecules, chemical exchange between the paramagnetic molecule and its 
environment, and the interaction of nearby molecules having unpaired spins are some 
examples of environmental effects which can influence line width and intensity in the EPR 
spectrum. Moreover, an observed spectrum can split in several lines referred to as 
hyperfine structure, arising from the electrons interacting with surrounding nuclear spins. 
This last property becomes very useful when investigating biological molecules that 
contain transition metal ions in their structure, since it can be exploited to characterize their 
coordination environment in dependence of their intrinsic geometry. 
 
2.6.3. Mass spectrometry 
 
Mass spectrometry is an analytical tool used for measuring the molecular mass of a sample. 
For large samples such as biomolecules, molecular masses can be measured with an 
accuracy of 0.01% of the total molecular mass of the sample. Mass spectrometry can be 
used for different types of characterization: 
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 Accurate molecular weight measurements, to determine the purity of a sample, to 
verify amino acid substitutions, to detect post-translational modifications, to calculate 
the number of disulphide bridges; 
 Reaction monitoring: monitor enzyme reactions, chemical modification, protein 
digestion; 
 Amino acid sequencing: sequence confirmation, characterisation of peptides, 
identification of proteins by databases from proteolytic fragmentation; 
 Protein structure: protein folding monitored by H/D exchange, protein-ligand complex 
formation under physiological conditions, macromolecular structure determination. 
Mass spectrometers can be divided into three fundamental parts: the ionisation source, the 
analyser and the detector.  
Sample molecules are ionised in the ionisation source, these ions are extracted into 
the analyser region of the mass spectrometer where they are separated according to their 
mass (m)-to-charge (z) ratios (m/z) . The separated ions are detected and this signal sent to 
a data system where the m/z ratios are stored together with their relative abundance for 
presentation in the format of a m/z spectrum. Many ionisation methods are available, each 
with its own advantages and disadvantages, and the choice depend on the type of sample 
under investigation and the mass spectrometer available. The ionisation methods used for 
the majority of biochemical analyses are Electrospray Ionisation (ESI) and Matrix Assisted 
Laser Desorption Ionisation (MALDI). 
The main function of the mass analyser is to separate, or resolve, the ions formed in 
the ionisation source of the mass spectrometer according to their mass-to-charge (m/z) 
ratios. There are a number of mass analysers currently available, including quadrupoles, 
time-of-flight (TOF) analysers, magnetic sectors, both Fourier transform and quadrupole 
ion traps, and Orbitrap. These mass analysers have different features, including the m/z 
range that can be covered, the mass accuracy, and the achievable resolution.  
The detector monitors the ion current, amplifies it and the signal is then transmitted 
to the data system where it is recorded as mass spectra. The m/z values of the ions are 
plotted against their intensities to show the number of components in the sample, the 
molecular mass of each component, and the relative abundance of the various components 
in the sample.  
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MALDI is widely used in biochemical areas for the analysis of proteins, peptides, 
glycoproteins, oligosaccharides, and oligonucleotides and it is usually performed in 
denaturing conditions. MALDI is based on the bombardment of sample molecules with a 
laser light to bring about sample ionisation. The sample is pre-mixed with a highly 
absorbing matrix compound which transforms the laser energy into excitation energy for 
the sample, which leads to sputtering of analyte and matrix ions from the surface of the 
mixture.
20
 
The time-of-flight (TOF) analyser separates ions according to their mass (m)-to-
charge (z) (m/z) ratios, by measuring the time it takes for ions to travel through a field free 
region known as the flight tube. The heavier ions are slower than the lighter ones. In 
negative ionisation mode, the deprotonated molecular ions (M-H-) are usually the most 
abundant species, accompanied by some salt adducts and possibly traces of dimeric or 
doubly charged materials. Negative ionisation can be used for the analysis of 
oligonucleotides and oligosaccharides. In positive ionisation mode, the protonated 
molecular ions (M+H+) are usually the dominant species, although they can be 
accompanied by salt adducts, a trace of the doubly charged molecular ion at approximately 
half the m/z value, and/or a trace of a dimeric species at approximately twice the m/z 
value. Positive ionisation is used in general for protein and peptide analyses.
21
 
In Orbitrap ions are electrostatically trapped in an orbit around a central, spindle 
shaped electrode. The electrode confines the ions so that they both orbit around the central 
electrode and oscillate back and forth along the central electrode's long axis. This 
oscillation generates an image current in the detector plates which is recorded by the 
instrument. The frequencies of these image currents depend on the mass to charge ratios of 
the ions. Mass spectra are obtained by Fourier transformation of the recorded image 
currents. Orbitraps have a high mass accuracy, high sensitivity and a good dynamic 
range.
22
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2.6.4. Circular dichroism  
 
Circular dichroism (CD) is an excellent method to analyze protein and nucleic acid 
secondary structure in solution and it can be used to follow the changes in folding as a 
function of temperature or denaturant. CD is a phenomenon occurring when asymmetrical 
molecules interact with circularly polarized light, thus absorbing left and right hand 
circularly polarized light with different absorption coefficients. In proteins the major 
optically active groups are the amide bonds of the peptide backbone, typically disposed in 
highly ordered arrays such as α-helices or β-pleated sheets. In dependence of the 
orientation of the peptide bonds in the arrays, given by the symmetry of its disposition, 
optical transitions are differently split by exciton splitting, thus yielding characteristic 
spectral profiles for each of the three basic secondary structures of a polypeptide chain.             
A protein consisting of these elements will therefore display a spectrum that can be 
deconvoluted into the tree individual contributions; for this purpose several mathematical 
methods have been developed, all of them relying on the assumption that the spectrum of a 
protein can be represented by a linear combination of the spectra of its secondary structural 
elements, plus a noise term which includes the contribution of aromatic chromophores. 
Circular dichroism spectroscopy is particularly good to: 
 Determine whether a protein is folded, and if so characterizing its secondary structure;  
 Compare the structures of a protein obtained from different sources (e.g. species or 
expression systems) or comparing structures for different mutants of the same protein;  
 Study the conformational stability of a protein under stress (thermal stability, pH 
stability, and stability to denaturants) and how this stability is altered by buffer 
composition or addition of stabilizers; 
 Determine whether protein-protein interactions alter the conformation of the protein. 
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2.6.5. NMR – protein structural characterization  
 
Discovering the tertiary structure of a protein, or the quaternary structure of its 
complexes, can provide important clues about how the protein performs its function. 
Nuclear Magnetic Resonance (NMR) is an experimental method of structure determination 
that can produce information at atomic resolution. NMR experiments are able to provide 
information from which a subset of distances between pairs of atoms can be estimated, and 
the final possible conformations for a protein are determined by solving a distance 
geometry problem. Moreover NMR spectroscopy is unique among the methods available 
for three-dimensional structure determination of proteins at atomic resolution, since the 
NMR data can be recorded in solution. Considering that body fluids such as blood, 
stomach liquid and saliva are protein solutions where these molecules perform their 
physiological functions, knowledge of the molecular structures in solution is highly 
relevant. Furthermore, in addition to protein structure determination, NMR applications 
include investigations of dynamic features of the molecular structures, as well as studies of 
structural, thermodynamic and kinetic aspects of interactions between proteins and other 
solution components, which may either be other proteins or low molecular weight 
ligands.
23,24 
The preparation of the protein sample is a crucial step of this process, since a highly 
purified protein sample is required. Inhomogeneous preparation and/or aggregation of the 
protein as well as low molecular weight impurities may severely harm the structure 
determination. The NMR technique exploits the property that magnetic nuclei, with an 
uneven spin quantum number such as the isotopes 
1
H, 
2
H, 
13
C, 
15
N, have in a magnetic 
field an energy splitting. Therefore, protein isotope labeling is necessary for NMR analysis 
because not all atoms are magnetically active. An applied electromagnetic (EM) pulse 
causes the nuclei to absorb energy, transient time domain signals are detected as the system 
returns to equilibrium. Fourier transformation of the transient signal into a frequency 
domain yields a one-dimensional NMR spectrum, which is a series of resonances from the 
various nuclei at different frequencies, or chemical shifts. The chemical shift of an atom 
depends on the electronic environment of its nucleus. Ideally, each distinct nucleus in the 
molecule experiences a distinct chemical environment and thus has a distinct chemical 
shift by which it can be recognized. However, in large molecules, such as proteins, the  
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number of resonances can be several thousand and a one-dimensional spectrum inevitably 
has overlaps. For this reason, protein NMR spectra cannot be resolved in a conventional 
one-dimensional spectra (1D) and multi-dimensional nuclear magnetic resonance 
spectroscopy is required to correlate the frequencies of different nuclei. Multi-dimensional 
NMR spectra provide both, increased resolution and correlations which are easy to analyse.   
There are different types of experiments that can detect through-bonds and through-
space nucleus/nucleus interactions. The 
1
H-
15
N HSQC (Heteronuclear Single Quantum 
Correlation) experiment is probably the most frequently recorded experiment in protein 
NMR. Each residue of the protein (except proline) has an amide proton attached to 
nitrogen in the peptide bond. If the protein is folded, the peaks are usually well dispersed, 
and most of the individual peaks can be distinguished. Being a relatively cheap and quick 
experiment, the HSQC is useful to screen candidates for structure determination by NMR. 
The number of peaks in the spectrum should match the number of residues in the protein 
(though side chains with nitrogen-bound protons will add additional peaks). It will 
probably be difficult to solve the structure of the protein if this is not the case. The labour-
intensive process of structure determination is usually not undertaken until a good HSQC 
spectrum is obtained. In order to analyze the nuclear magnetic resonance data, it is 
important to get a resonance assignment for the protein. That is to find out which chemical 
shift corresponds to which atom. This is typically achieved by sequential walking using 
information derived from several different types of NMR experiment. 
For small proteins (less than 10 kDa), it is not required to label the sample with 
13
C 
or 
15
N. With unlabelled protein the usual procedure is to record a set of two dimensional 
homonuclear NMR experiments through correlation spectroscopy (COSY), of which 
several types include conventional correlation spectroscopy, total correlation spectroscopy 
(TOCSY) and nuclear Overhauser effect spectroscopy (NOESY). TOCSY gives 
information about different nuclei via J coupling and through-bond correlations, whereas 
NOESY gives information about correlations through space.
25,26 
Homonuclear NMR is 
usually restricted to small proteins or peptides because of the signal overlap problem in the 
case of bigger proteins. This occurs when different protons have the same or very similar 
chemical shifts, and becomes greater as the protein becomes larger. 
This barrier can be overcome with 3D NMR techniques and uniformly 
13
C and 
15
N 
labelled proteins. In the case of labelled proteins it is possible to record an experiment that 
transfers magnetization over the peptide bond, and thus connects different spin systems 
through bonds. The 3D experiments exclusively correlate the resonances of the protein 
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backbone, and the experiments used are: HNCA, HNCACB, HN(CO)CA, HN(CO)CACB, 
HNCO and HN(CA)CO.  
In the case of proteins with a molecular weight larger than 30 kDa the use of 
TROSY (Transverse Relaxation Optimized Spectroscopy) experiments is necessary. The 
TROSY technique benefits from a variety of triple resonance NMR experiments as the 3D 
HNCA and HN(CO)CA. 3D H(C)CH-TOCSY and (H)CCH-TOCSY experiments are then 
used to link the side chain spin systems to the backbone assignments.
27,28 
Protein NMR techniques are continually being used and developed. Improvements 
in NMR hardware (magnetic field strength, cryoprobes) and NMR methodology, combined 
with the availability of molecular biology and biochemical methods for preparation and 
isotope labeling of recombinant proteins, have dramatically increased the use of NMR for 
the characterization of structure and dynamics of biological molecules in solution. 
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 Beside their well-established function in energy supply for all cell compartments, 
mitochondria are also the primary source of iron-sulfur (Fe/S) clusters that are utilized by 
proteins throughout the cell.
1
 Such Fe/S cluster proteins have essential functions in 
metabolism, electron transport and regulation of gene expression. Despite the relative 
simplicity of Fe/S clusters in terms of structure and composition, their synthesis and 
assembly is a highly complex and coordinated process which yet has not been understood 
in a comprehensive way.
2,3,4
 Defects in human Fe/S protein biogenesis are responsible of 
numerous diseases like e.g. Friedreich’s ataxia or sideroblastic anemia.5,6 The cluster 
biogenesis in eukaryotes involves three distinct machineries localized in two different 
cellular compartments:  i)  the  iron-sulfur  cluster  (ISC)  assembly machinery and  ii) the 
ISC export machinery, both in  mitochondria, and  iii)  the  cytosolic  iron-sulfur cluster 
assembly (CIA) machinery in the cytoplasm.
7
 The components of the ISC  assembly 
machinery are similar to  the proteins mediating Fe/S cluster assembly in bacteria  and 
apparently were inherited from the prokaryotic ancestor of mitochondria.
8
   
 Generation of extra-mitochondrial (both cytosolic and nuclear) Fe/S proteins 
requires a yet unidentified product of the ISC assembly pathway in mitochondria. This 
compound is exported to the cytosol by the ISC export machinery whose central 
component is an ABC transporter in the mitochondrial inner membrane.  The export 
reaction is  assisted  by the sulfhydryl oxidase Erv1/ALR and glutathione in the IMS.
4,9,10
  
 In yeast, a protein, Dre2, has been recently suggested to be implicated in the 
cytosolic Fe/S protein maturation.
11
   Dre2 is a Fe/S cluster protein and the phenotypes of 
dre2 mutants or of Dre2-depleted cells are similar to those caused by alteration of CIA 
components. It has recently also been found that the diflavin reductase Tah18, which is also 
part of the yeast CIA machinery, forms a complex with Dre2 in the cytosol. This complex 
is part of an electron transfer chain functioning in an early step of the cytosolic Fe/S 
protein biogenesis.
12
 The pathway is conserved in mammals as the human counterparts, 
Ndor1 and CIAPIN1,  are able  to functionally replace  the  yeast Tah18 and Dre2 proteins  
in yeast  and to  form a stable complex  like  the yeast homologues. However, at variance 
with all the other CIA protein components, for which no mitochondrial localisations have 
ever been reported, a fraction of Dre2 is localized in the mitochondrial IMS.
11
  
Additionally, it has  been reported that  Tah18 relocalises to the mitochondria  to act as a 
molecular sensor for high oxidative stress levels that involves mitochondria and accurately 
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controls an oxidative induced cell death pathway in yeast.
13
 
 How the dual mitochondrial/cytoplasmic localization of Dre2 and Tah18 is 
accomplished is still unknown. Since Dre2 has two CX2C motifs, similar to some other 
IMS proteins, it has been proposed that the dual cellular protein distribution might be 
explained by a yet unknown process of folding of the Dre2 precursor outside mitochondria 
which competes with the oxidative folding (and trapping) inside the IMS performed by 
Mia40 and Erv1.
11
 The latter proteins trap in the IMS a class of mitochondrial proteins 
having characteristic cysteine motifs (twin CX3C or CX9C, or CX2C). Specifically, the 
mitochondrial protein can be directed to the IMS by targeting signals that allow passage 
through the import translocase; subsequently, it can be retained within  this compartment 
by  interaction with the Mia40 protein partner which catalyses the formation of two 
disulphides between the twin cysteine motifs of the substrate.
14,15
  The human homologue 
of yeast Dre2,  called anamorsin or CIAPIN1 (hereafter named as anamorsin) has  not only  
been  associated with Fe/S cluster assembly, but  it has been  also identified as a necessary 
molecule for hematopoiesis which mediates antiapoptotic effects of various cytokines 
(Cytokine-Induced Apoptosis Inhibitor 1), without sharing any homology to known 
apoptosis regulatory molecules such as Bcl-2 family, caspase family, or signal transduction 
molecules.
16
 Additionally, anamorsin was reported to be involved in the development of 
multidrug resistance in gastric and leukemia cells.
17
 Several preclinical studies have also 
demonstrated that anamorsin is associated with increased tumor recurrence and shorter 
patient survival in different human tumor models, making anti-anamorsin therapy a new 
cancer treatment strategy.
18
 Anamorsin is therefore an extremely important molecule 
playing a crucial role in cellular survival. To contribute to the comprehension of the 
possible functional role of anamorsin in the IMS, we have investigated in this work the 
structural and metal binding properties of anamorsin as well as its interaction with Mia40. 
From this molecular analysis we conclude that anamorsin is a Mia40-substrate able to bind 
a 2Fe2S cluster before and after the Mia40-driven  Cys-oxidation, in agreement with a 
possible role of anamorsin  in the Fe/S cluster biogenesis also once localized in the 
intermembrane space of mitochondria. 
 
 
 
 
 
Results-Anamorsin 
57 
 
 
 
Bioinformatic analysis 
 
 Homologous sequences to anamorsin were searched via BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) in the database of non-redundant protein sequences  
using Blastp (protein-protein BLAST). All the sequences were then divided into domains 
using the Pfam/SMART databases.
19
 Sequence alignments were then performed on the 
full-length sequences and on the identified domains, using the ClustalW program and 
default parameters.
20
 The folding probability was predicted by the algorithm FoldIndex©.21  
Homologous structures to the N-terminal domain of anamorsin were identified via the 
DALI server (http://ekhidna.biocenter.helsinki.fi/dali_server/).
22
 
 
Molecular cloning, expression and purification of full-length, N-terminal domain and 
C-terminally truncated (1-270aa) anamorsin 
 
 The cDNA coding for the human protein anamorsin (UniProtKB/Swiss-Prot:  
Q6FI81, Genbank Accession No. BC024196) was commercially acquired from Imagenes 
(ORF shuttle Clone IOH4051) and after amplification by PCR inserted into the Gateway® 
pEntr-TEV-d-Topo vector (InvitrogenTM). For recombinant expression it was cloned via 
the Gateway®technology (InvitrogenTM) into the expression vector pCold-DEST. This 
vector is based on the pColdI (Takara Bio Inc, Japan) and has been modified to make it 
suitable for the Gateway® system. According to the vector construction the protein is 
expressed with an N-terminal His12 tag and for the release from it a sequence coding for 
the specific recognition site of the TEV protease was located at the 5' end of the anamorsin. 
All the recombinant proteins contain four additional amino acids, GSFT, at the N-terminus. 
 BL21-CodonPlus (DE3)-RIPL Competent Cells (Stratagene, La Jolla, CA) were 
transformed with the anamorsin/pCOLD-DEST construct.  The cultures were grown at 
37°C under vigorous shaking overnight, diluted 1:100 into LB medium or minimal 
medium containing 100 µg/ml ampicillin and 34 µg/ml chloramphenicol and grown further 
at 37°C until OD600 reached 0.8-1. The culture was transferred to 25°C and protein 
expression was induced by addition of IPTG to  a final concentration of 0.2 mM and 
incubation was continued for 3 h (rich media) or 4 h (minimal media). The full-length 
anamorsin and C-terminally truncated construct were expressed in the presence of 125 µM 
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FeCl3. Subsequently, the cells were harvested by centrifugation (6000 x g, 15 min, 4°C) 
and the pellets were stored at -20°C. The frozen cell pellets were re-suspended in degassed 
lysis buffer (Tris-HCl 50mM, NaCl 500mM, glycerol 5%, imidazole 20mM, pH 8) 
containing lysozyme (0,25mg/ml), DNA-se I (0.01mg/ml) and MgSO4 (40mM). Cells 
were incubated on ice for 30 min with gentle shaking and subsequently, disrupted on ice by 
sonication alternating 30  seconds of sonication and 5 minutes of resting for 10 times. The 
resulting cell lysate was centrifuged (20000 x g, 40 min, 4°C). Employing the N-terminal 
His tag, all the proteins were purified by immobilized metal ion affinity chromatography, 
under anaerobic conditions in a glove box for the full-length protein and the C-terminally 
truncated construct and under aerobic conditions for the N-terminal domain. The 
supernatant was applied to a nickel-charged HiTrap chelating HP column (Amersham 
Pharmacia Biosciences) and  anamorsin constructs were eluted with degassed elution 
buffer (50mM Tris-HCl, 500mM NaCl, 500 mM imidazole, 5% glycerol, pH 8) and 
concentrated  in presence of 3mM DTT with an Amicon Ultra-15 Centrifugal Filter Units 
with a MWC of 10 kDa (Millipore). The His-tag was cleaved from the recombinant 
proteins by incubation with TEV protease (3µl TEV/1mg anamorsin) and used for reverse 
Ni(II) affinity chromatography in order to remove the cleaved His-Tag. Size exclusion 
chromatography was performed as the final purification step using a HiLoad 16/60 
Superdex 75 pg column (GE Healthcare) and degassed 50mM Tris-HCl, 500mM NaCl, 
2mM DTT, 5% glycerol, pH 8 as a running buffer. The protein was used directly for 
analysis or frozen in liquid nitrogen and stored at -80°C.                                              
 Degradation of the full-length anamorsin was followed by MALDI-MS. 1 µl of 
protein solution was mixed with a 1 µl of matrix solution (SA 10 mg/ml in 70 % 
acetonitrile/30% water, 0.1% TFA) and analysed on a MALDI TOF/ TOF mass 
spectrometer Ultraflex III (Bruker Daltonics, Bremen, Germany) by using Flex Control 3.0 
as data acquisition software in positive linear mode. The instrument was externally 
calibrated prior to analysis using the Bruker Protein I calibrant standard kit (5-17 kDa). 
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Reconstitution of 2Fe2S-anamorsin 
 
 Purified full-length anamorsin  or C-terminally truncated construct  was dialyzed 
(MWC:10kDa) against the 500-fold volume of degassed reconstitution buffer (50 mM Tris-
HCl, 200 mM NaCl, 5 mM DTT, pH 7.5) containing 10-fold molar excess of FeCl3 and 
Na2S for 8h at 25°C. To remove unbound ions, the mixture was exchanged with fresh 
reconstitution buffer (without FeCl3 and Na2S) using PD-10 Desalting column (Amersham 
Biosciences) and then the reconstituted protein was further dialysed at 4°C for 12h. All the 
reconstitution experiments were performed under anaerobic conditions  and in dark. The 
apo-form of anamorsin was prepared according to the procedure published by Kennedy et 
al.
23
 
 
Iron and sulfide quantification 
 
 Iron concentration and sulfide content of purified, reconstituted anamorsin were 
determined by colorimetric assays. To estimate the iron content a standard procedure has 
been followed with few modifications.
11
 350µL of each sample dilution were treated with 
50µl of 5% SDS for 5 minutes and then reduced with 50µl of 10mM sodium dithionite 
followed by addition of 50µl of 10mM bathophenanthrolinedisulfonic acid disodium salt to 
chelate iron(II). Samples were incubated in the dark for 20 minutes, mixed and centrifuged 
for 5 minutes at 12000 x g. Absorbance at 515nm was measured and the concentration was 
estimated through standard curve analysis using NH4Fe(SO4)2. To estimate the sulfide 
content, a standard procedure has been followed with few modifications.
24
 Samples 
(600µl) were treated with 50µl of 6% NaOH and incubated for 5 minutes. Samples were 
mixed with 125µl of 0.1% DPD (N,N-dimethyl-p-phenylenediamine dihydrochloride, 
Sigma-Aldrich) followed by addition of 50µl of 11.5 mM FeCl3 and incubated for 30 
minutes at room temperature. Sulfide concentration was estimated at 670nm through 
standard curve analysis using sodium sulfide Na2S. 
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UV/Vis, EPR and NMR spectroscopy 
 
 UV-visible spectra of oxidized and reduced 2Fe2S-anamorsin in degassed 50mM 
phosphate buffer at pH 7.0 were performed on a Cary 50 Eclipse spectrophotometer. EPR 
spectra of oxidized and reduced 2Fe2S-anamorsin in 50mM Tris-HCl pH 8.0, 500mM 
NaCl or 50mM phosphate buffer at pH 7.0  and 10% glycerol  was performed on a Bruker 
Elexsys E500 spectrometer equipped with a X-band microwave bridge (microwave 
frequency, 9.45 GHz) and an ER 4131 VT (unit for temperature control).  EPR parameters 
were the following: sample temperature 45K, microwave frequency 9.45 GHz ; microwave 
power 5 mW; modulation frequency 9,387691 GHz; modulation amplitude 2500 G, time 
constant 167 ms. To reduce the cluster, 1 to 10 mM dithionite was added under anaerobic 
conditions and the sample was immediately frozen. 
1
H paramagnetic NMR spectra of 
2 mM oxidized 2Fe2S-anamorsin (50 mM phosphate buffer pH 7.0 in D2O, 1mM DTT) 
were recorded on a Bruker Avance 600 MHz spectrometer equipped with a selective 
1
H 
probe head (5 mm SEL 
1
H) at 298 K. All 1D spectra were taken by using a super WEFT 
pulse sequence with a recycle delay of 54 ms.
25
   
15
N R1, R2, and steady-state heteronuclear 
NOE measurements were performed at 14.1 T (600MHz), 298K, using the pulse sequences 
proposed by Farrow  et al. on 
15
N-labeled samples.
26,27
 The overall rotational correlation 
time values were estimated from the R2/R1 ratio using the program 
QUADRATIC_DIFFUSION (Lee, et al., 1997).
28
 The relaxation data for those NHs having 
an exchange contribution to the R2  value or exhibiting large-amplitude internal motions, as 
monitored by low NOE values, were excluded from the analysis.  
 
Interaction of anamorsin with Mia40 
 
 The cysteine mutant (C4S) of the Mia40 protein was recombinantly expressed and 
purified as described previously in Banci  et al.  (Banci, et al., 2009)with the exception that 
the BL21-Gold(DE3)  E. coli  strain (Stratagene, La Jolla, CA) was used for protein 
expression. The protein was oxidized with 10 mM K3[Fe(CN)6] (Sigma-Aldrich) for 75 
min at 4°C in order to assure the formation of all three disulfide bonds. K3[Fe(CN)6] was 
then removed by a PD-10 column. 
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 To monitor the interaction by NMR, titrations of 
15
N-labeled apo- or 2Fe2S-
anamorsin with unlabeled Mia40 and of unlabeled apo-  or 2Fe2S-anamorsin with 
15
N-
labeled Mia40 were performed in anaerobic conditions. Chemical shift changes were 
followed by 
1
H-
15
N HSQC spectra after addition of increasing amounts of the unlabeled 
partner. 
 To detect Mia40-induced disulfide formation in anamorsin by MALDI-MS, a full-
length 2Fe2S-anamorsin sample was divided into two aliquots I and II (50 µl each). 
Sample II was mixed with 12.5 µl of 700 µM Mia403S-S (phosphate buffer 50 mM pH 
7.0, 0.5 mM EDTA) and incubated at room temperature for 5 minutes. Both samples were 
then precipitated with 20% TCA, subsequently washed with acetone and re-suspended in 
50µl of degassed buffer (Tris-HCl 50 mM, Urea 8M pH 7.5 ). 10µl of freshly prepared 100 
mM  IAM were added to each sample and the mixture was incubated in anaerobic 
conditions at 25°C in the dark for 1h. Reacted samples were applied on a SDS-PA gel and 
run without addition of DTT, so that all the cysteine residues that are not involved in 
disulfide bonds have to carry the IAM modification. Bands corresponding to anamorsin 
from both sample I and II were excised from the gel and individually transferred to a 1.5 
ml microcentrifuge tube. Spots were washed three times for about 10 min in 40 μl  of 
acetonitrile and then in 40 μl  of a 0.1 M ammonium bicarbonate water solution. The 
solution was removed and digested either with trypsin or chymotrypsin. 30 μl of a 1 ng/µl  
of modified trypsin (Promega, Madison, WI) in 10 mM ammonium bicarbonate was added 
to each spot. Samples were kept at 4 °C for 30 min, then the solution was removed and 
replaced with 25 μl of 10 mM ammonium bicarbonate. After overnight digestion at 37 °C, 
the supernatant was recovered and the reaction blocked by addition of 1 μl of 10% TFA. 
For chymotrypsin digestion, 10 μl of a 100 ng/ μl of the enzyme dissolved in AMBIC 25 
mM, CaCl2  10 mM were added to the gel pieces. Digestion  was proceeded overnight at 
37°C and stopped by addition of 1 μl of 10% TFA and analysed by MALDI-MS. 0.3 μl  of 
matrix solution (HCCA 10 mg/ml  in 70 % acetonitrile/30% water, 0.1% TFA) were mixed 
with 0.3 μl of the digested proteins on an anchorchip target (600 μm diameter). Spectra 
were acquired in positive Reflecton mode linear mode over the m/z range 800-5,000. The 
instrument was externally calibrated prior to analysis using the Bruker Peptide calibrant 
standard kit (1046-3147Da).   
 ESI-MS  data were  acquired in positive ion mode, setting the spray voltage at 4 kV, 
the capillary voltage and temperature respectively at 45 V and  220 °C, and the tube lens at 
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230V. For acquisition, Xcalibur 2.0 software (Thermo) was used and monoisotopic and 
average deconvoluted masses were obtained by using the integrated Xtract tool. For spectra 
acquisition a nominal resolution (at m/z 400) of 100.000 was used. 
 
NMR spectroscopy and structure calculations 
 
 All NMR spectra were recorded at 298K using Bruker Avance 500, 600 and 900 
MHz spectrometers, processed using the standard Bruker software Topspin and analyzed 
by the program CARA  (Keller, 2004).
29
 The NMR experiments used for resonance 
assignment and structure calculations were performed on 0.4-1 mM 
13
C, 
15
N-labeled and 
15
N-labeled samples of the N-terminal domain of anamorsin (aa 1-172) in 50 mM 
phosphate buffer pH 7, 2 mM DTT containing 10% (v/v) D2O. The 
1
H, 
13
C and 
15
N 
backbone resonance assignment was performed using standard triple-resonance NMR 
experiments and side chain assignment using TOCSY- and NOESY-based NMR 
experiments. Completeness of all atom assignment: 92.56%, completeness of proton atom 
assignment: 94.34%, completeness of heavy atom assignment: 90.37%. 
 Structure calculations were performed with the software package UNIO 
(ATNOS/CANDID/CYANA)
30,31,32
, using as input the amino acid sequence, the chemical 
shift lists, four [
1
H,
1
H]-NOE experiments (two-dimensional NOESY, three-dimensional 
15
N-resolved NOESY and two different three-dimensional 
13
C-resolved NOESY), ψ and φ 
backbone torsion angle constraints, derived from 
1
H, 
13
C and 
15
N chemical shifts through 
the program TALOS+
33
 were also used in the structure calculations. The protein hydrogen-
bonding database potential (HBDB)
34
 was also used at the structure refinement stage. The 
30 conformers with the lowest residual target function values were subjected to restrained 
energy minimization in explicit water with the program AMBER 10.
35
  The quality of the 
structures was evaluated by the programs PROCHECK, PROCHECK-NMR, WHAT IF, 
PSVS (Bhattacharya, et al., 2007) and iCing (http://nmr.cmbi.ru.nl/cing/iCing.html).
36,37,38
 
The conformational and energetic analyses of the final REM family of 30 structures are 
reported in Table S2. The Ramachandran plot of the 30 conformers (aa 2-165) shows that 
88.7% of the residues lie in the most favorable region of the plot, 10.2% in the allowed 
region, 1% in the generously allowed and 0 % in the disallowed regions. 
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Anamorsin has a CIAPIN1 domain potentially responsible of its IMS trapping 
through the mitochondrial Mia40-Erv1 machinery 
 
Bioinformatic analysis shows that a CIAPIN1 domain is present in the anamorsin amino 
acid sequence. The CIAPIN1 domain contains a highly conserved Cys-rich motif, 
i.e. CX5 -14CX2CXCXnCX2CX7CX2C  (Fig. 1A), and is  present in  182  sequences  found  
in 103 eukaryotic  species  (average length of the domain 85 a.a.).  In these proteins the 
CIAPIN1 domain is typically located at the C-terminus and can be fused to other 
functional domains. In anamorsin, the CIAPIN1 domain is fused at the N-terminus to a 
methyltransferase-like domain. Secondary structure and folding predictions  reveal  that 
these two domains are separated by an unstructured amino acid linker of ~ 50 residues 
(Fig. 1B) and that a large part of the CIAPIN1 domain, in particular its initial segment 
(residues 222 to 266), is structurally highly disordered, while the final segment is predicted 
to be more structured (Fig. 1B). The latter region of the CIAPIN1 domain contains a twin 
CX2C motif while the initial segment of the CIAPIN1 domain contains the additional four 
cysteines of the Cys-rich motif (Fig. 1B). Since it has been shown that the highly 
homologous yeast protein, Dre2, is able to bind a Fe/S cofactor, it is likely that cysteines 
from this Cys-rich motif in anamorsin are involved in iron binding.
11
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Figure 1. Bioinformatic analysis of anamorsin.  (A) Sequence alignment of the CIAPIN1 domain 
conserved in 182 sequences by using LogoMat-M visualization tool.
39
 The relative size of a letter 
expresses its probability to occur at this position in the sequence alignment.  Pink column  indicates 
an insert region of a number of residues with no conservation in the sequence alignment. (B) 
Folding prediction of anamorsin derived from FoldIndex program.
21
 Regions shaded in green are 
predicted to be in a folded state, while red shaded regions are predicted to be unfolded. 
 
In cell fractionation studies, anamorsin was found in the cytoplasm, nucleus, and 
nucleolus, while mitochondria were not specifically examined.
40
 Accordingly, 
bioinformatic predictors show the presence of a putative nuclear localization signal and a 
putative leucine-rich nuclear export signal, while the typical mitochondrial matrix targeting 
signals are not bioinfomatically predicted.
40
 However, the yeast Dre2 homologue has been 
shown to be localized in the IMS and it has been proposed to be a partner of  the Mia40-
Erv1 IMS-trapping machinery.
11
 Mia40 is involved in the recognition of IMS-imported 
proteins typically containing a twin CX9C or CX3C motif or CX2C motif.
41,42,43
 Recently, 
a hydrophobic IMS-targeting signal (ITS)  located  close to these twin CX9C or CX3C 
motifs in Mia40 substrates has been identified.
44,45
 This ITS sequence is able to promote 
the docking of the substrate into a hydrophobic cleft of Mia40 which is then able to 
catalyze the formation of disulfide bond(s) in the substrate, thus trapping Mia40 substrates 
in the IMS. Anamorsin has a twin CX2C motif at the C-terminus of the CIAPIN1 domain 
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that could potentially be recognized and oxidized by Mia40. According to this proposal, 
sequence comparative analysis shows that the CIAPIN1 domain has highly conserved 
hydrophobic residues following the last cysteine of the twin CX2C motif, strongly 
suggesting that it could act as a possible  ITS recognizable by Mia40. In conclusion, this 
analysis suggests that anamorsin could potentially be trapped in the  
IMS through the Mia40-Erv1 machinery. 
 
Anamorsin contains a well-folded N-terminal domain and an unstructured, flexible  
C-terminal part carrying a Fe/S cluster 
 
Recombinant expression of anamorsin in the presence of iron and subsequent purification 
results in a reddish-brown protein solution indicating the presence of a  Fe/S  cluster. The 
protein is monomeric in solution and degrades within 7-10 days at room temperature under 
anaerobic conditions resulting into a stable fragment of 19 kDa (Fig. 2). During 
degradation the color of the solution is lost and mass spectrometry analysis revealed that 
the stable fragment is constituted by the N-terminal part (aa 1-172) of the protein. This part 
does not contain the CIAPIN1 domain and, accordingly, neither the cysteines potentially 
involved in the coordination of the Fe/S cluster. The 
1
H-
15
N HSQC spectra of the full-
length protein (Fig. 2A) shows highly crowded cross-peaks in the spectral region between 
8 and 8.5 ppm indicating that the protein contains an unstructured region, in addition to 
several signals spread over a larger spectral range, indicative of folded conformations. 
After degradation, the 
1
H-
15
N HSQC spectrum of the resulting fragment (Fig. 2B) shows 
the disappearance of many of the signals in the crowded, central region, while the well-
resolved resonances are still present and do not show significant chemical shift changes. 
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Figure 2. Structural properties of anamorsin. (A) 
1
H-
15
N HSQC spectrum at 500 MHz and 308K 
of a freshly purified 2Fe2S-anamorsin. SDS PAGE of the corresponding sample. (B)
 1
H-
15
N HSQC 
spectrum at 500 MHz and 308K of anamorsin recorded after 10 days of incubation under anaerobic 
conditions. SDS PAGE of the corresponding sample after 10 days. Anamorsin degraded into a 
stable fragment of ~19 kDa. PD10 column was performed under anaerobic conditions before 
recording the NMR spectrum to remove smaller degradation fragments. NH signals clustered in the 
central region of 
1
H-
15
N HSQC spectrum of the freshly purified anamorsin disappear after its 
degradation. (see also Fig. S1). 
 
 
15
N{
1
H} NOEs experiments on the full-length anamorsin showed that  the residues 
not belonging to the N-terminal domain (which are in the highly crowded spectral region 
between 8 and 8.5 ppm) exhibited negative or very low NOEs, indicative of a high degree 
of flexibility in the C-terminal part of the protein  (Fig. S1). We can conclude that the N-
terminal part is well-folded while the C-terminal part is largely unstructured and flexible, 
and therefore, highly prone to degradation. Comparison of the signals that can be 
unambiguously assigned in both, the full-length and the N-terminal domain 
1
H-
15
N HSQC 
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spectra (70 spread over the entire sequence), shows similar chemical shifts with average 
weighted  ΔHN  values being smaller than 0.05 ppm (Fig. S1) (except for two residues at the 
beginning and the last residues of the N-terminal domain). This result indicates that there 
are no interactions between the N- and C-terminal domains in the full-length protein and  
that  the cysteines involved in  Fe/S coordination are all part of the CIAPIN1 domain. 
 
Anamorsin coordinates a 2Fe2S cluster in the CIAPIN1 domain 
 
The binding motifs for the different  Fe/S  clusters in proteins are not highly conserved, yet 
some consensus motifs have been recognized.
7,46
  In particular, the binding motifs for the 
different 2Fe2S cluster proteins were divided into three main groups.
2,47
  However, 
comparison of the anamorsin cysteine motifs with these groups gave no clear hint on the 
kind of cluster. 
 Chemical reconstitution of full-length anamorsin with a 10-fold access of iron and 
sulfur in the presence of DTT resulted in an enhanced intensity of its reddish-brown color. 
After in vitro binding of the cluster to the protein, the absorbance ratio A420/A280 (which is 
an indicator of the structural integrity of the cluster) is around 0.38, in good agreement 
with that of spinach ferredoxin, and shows that nearly all protein molecules are loaded with 
the cluster.
48
  At a protein concentration of 76 µM the amount of iron and sulfur is 
determined to be 150 µM and 157 µM, respectively. This ratio of Fe:S:protein of 2:2:1 
after cluster reconstitution has been achieved in all preparations.  
 In the UV/vis spectra (Fig. 3A) an absorption peak at 333 nm and weaker, broad 
peaks at around 420 nm and 460 nm are observed,  that  are typical absorption features of 
2Fe2S clusters.
49
 These  absorbances  are  quenched  after  reduction of the cluster with 1 
mM dithionite (Fig. 3A inset). In a typical 2Fe2S cluster, absorption from 420 nm to 460 
nm is attributed to the  a charge transfer  transition  between  iron and bridging inorganic 
sulfur, whereas  absorption at 330 nm is a result of  a charge transfer  transition between 
the iron and cysteinyl sulfur of the polypeptide backbone.
49
 The protein with the oxidized 
cluster is EPR silent consistent with the presence of a S=0 [2Fe2S]
2+
 cluster.  Anaerobic 
addition of dithionite results in cluster reduction and the resulting spectra measured at 45K 
(Fig. 3B) exhibits a rhombic pattern with g values of gz 2.00, gy 1.96, gx 1.92, consistent 
with a S=1/2  [2Fe2S]
+
  cluster. The shape and the g-values are similar to those of plant-
like ferredoxins and identical g-values have been reported for the yeast homologue Dre2 
under these conditions.
11,50
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 The 600 MHz 
1
H paramagnetic NMR spectrum (Fig. 3C) of the oxidized protein at 
298K shows a broad peak around 34 ppm (CHβ-Cys protons) and a sharp signal at 10.5 
ppm (CHα-Cys protons). These signals are typical of proteins with 2Fe2S cluster.
51,52,53
  
 In conclusion, all these results indicate that anamorsin coordinates one 2Fe2S 
cluster per protein molecule. 
 
Figure 3. Anamorsin binds a 
2Fe2S cluster.  (A) UV-visible 
spectrum of 2Fe2S-anamorsin in 
50mM phosphate buffer, pH 7.0. In 
the inset, UV-visible spectra of 
anamorsin without (solid line) or 
with 1mM sodium dithionite 
(dashed line) are shown. The peaks 
at around 330, 420 and 460 nm of 
the spectrum of the oxidized cluster 
disappear upon reduction with 
dithionite. (B) EPR spectrum of 
2Fe2S-anamorsin (200 µM) in 
50mM Tris-HCl pH 8.0, 500mM 
NaCl and 10% glycerol in the 
presence of 1mM dithionite. EPR 
parameters were the following: 
sample temperature 45 K, 
microwave frequency 9.45 GHz ; 
microwave power 5 mW; 
modulation frequency 9,387691 
GHz; modulation amplitude 2500 
G, time constant 167 ms. (C) 
Paramagnetic 1H NMR spectrum of 
2Fe2S-anamorsin (2 mM) in 50mM 
phosphate buffer pH 7.0 at 600 
MHz and 298K. (see also Fig. S2). 
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Anamorsin is a Mia40 substrate 
 
 Following the suggestion of our bioinformatic sequence analysis and the 
localization results on the yeast homologue, we predict that anamorsin can be a putative 
substrate of Mia40 in the intermembrane space of mitochondria.
11
 Therefore, we have 
investigated the interaction of these two proteins in vitro. 
 The fully oxidized Mia40 containing three disulfide bonds (Mia403S-S) was 
incubated with anamorsin from which the  Fe/S  cluster was removed (apo-anamorsin)  and 
which therefore has ten free cysteines  (two in the N-terminal folded domain and eight in 
the CIAPIN1 domain). The analysis of the redox state of the two proteins after  their  
incubation, performed  by  reaction  with  4-acetamido-4′-maleimidylstilbene-2,2′-
disulfonic acid (AMS) and followed by SDS-PAGE,  showed that the band of Mia40  is 
shifted with respect  to the band of the fully oxidized Mia403S-S before reaction (Fig. 4A). 
This indicates that its cysteines were partially reduced upon incubation with anamorsin and 
therefore, they were able to bind two AMS molecules (0.5 kDa/thiol moiety). Anamorsin in 
the completely reduced state (before Mia40-incubation) binds ten AMS molecules resulting 
in a larger shift of the band (Fig. 4A). After incubation with Mia403S-S this shift is, 
however, decreased indicating that fewer AMS molecules were bound to anamorsin, as a 
consequence of the oxidation of some of its cysteine residues. 
 This redox process between  apo-anamorsin and Mia40 was then followed by 
NMR. Upon addition of increasing amounts of unlabelled reduced apo-anamorsin to 
15
N 
labeled Mia403S-S, NH chemical shift changes were detected in the 
1
H-
15
N HSQC spectra 
for Mia40 residues of the catalytic CPC motif and its surroundings, indicating its reduction 
(Mia402S-S, Fig. 4B). The observed chemical shift variations are fully comparable with 
those observed upon oxidation of typical IMS Mia40-substrates with twin CX9C motifs.
14
  
The reaction was complete at a Mia40:apo-anamorsin ratio of about 1:1 (Fig. 4C). The 
same behavior was observed when the NMR experiment was performed using anamorsin 
carrying the Fe/S cluster (2Fe2S-anamorsin hereafter). Moreover, the UV/vis and EPR 
spectra of 2Fe2S-anamorsin are identical after or before reaction with Mia40 (Fig. S2). All 
these data indicate that the coordination of the cluster is not affected by the formation of 
the Mia40-induced disulfide bond(s). 
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Figure 4.  Interaction of 
anamorsin with Mia40.  (A) 
17% SDS PAGE showing the 
redox state of anamorsin and 
Mia40 alone or after their 
incubation in the presence (+) or 
absence (-) of the cysteine-
alkylating agent AMS. After the 
incubation of the two proteins 
(lane 4) the band corresponding 
to Mia40 is shifted compared to 
the fully oxidized protein (lane 
1) indicating a partial reduction 
of the protein. The shift of the 
anamorsin band in line 4 is not as 
strong as without incubation with 
Mia40 (lanes 2 and 3) due to a 
partial oxidation of anamorsin. 
(B) Overlay of two selected 
regions of the 
1
H-
15
N HSQC 
spectra of 
15
N-labeled Mia40 in 
the presence of 0 (blue, Mia403S-
S) and 1.2 equivalents (red, 
Mia402S-S) of unlabeled apo-
anamorsin. (C) The plot reports 
Mia403S-S/Mia402S-S molar 
fraction as a function of the 
anmorsin/Mia40 molar ratio. The 
NH cross-peaks of residues 
Trp51, Cys53, Gly57 and Gly58, 
whose 1H- and 15N chemical 
shifts change substantially 
depending on the redox state of 
Mia40, have been selected to  
calculate  the Mia403S-S/Mia402S-
S molar fraction.  (see also Fig. 
S3).  
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When detecting 
15
N labeled 2Fe2S-anamorsin reacting with unlabeled Mia403S-S, no 
significant chemical shift variations were observed in the 
1
H-
15
N HSQC maps for the 
residues of the folded N-terminal domain, indicating that it is not involved in the reaction 
(Fig. S3). On the contrary, chemical shift variations are observed for NH signals in the 
crowded, central spectral region, indicating a structural rearrangement in the unstructured 
C-terminal region of anamorsin upon disulfide formation (Fig. S3). Mia40-induced 
oxidation of anamorsin also produces a dramatically enhanced stability as shown by SDS-
PAGE analysis (Fig. S3). 
 Carboxyamidomethylation with iodoacetamide (IAM) of the cysteine residues of 
2Fe2S-anamorsin was performed before and after incubation with Mia40 in order to 
investigate how many and which are the cysteine residues involved in the formation of the 
disulfide bond(s). After SDS-PAGE protein separation and proteolytic trypsin or 
chymotrypsin digestion,  the resulting  peptide  fragments were analyzed by MALDI-MS.  
For anamorsin not treated with Mia40, all the ten cysteines reacted with IAM (Table S1), 
while in the sample incubated with Mia40 the  last four cysteine residues (C274, C277, 
C285 and C288) did not react with IAM while the remaining six cysteine residues were 
modified (Table S1, Fig. 5). This means that the last four cysteine residues are involved in 
two disulfide bonds and consequently the other four upstream cysteines are coordinating  
the Fe/S cluster  (C237, C246, C249 and C251), as the remaining two IAM-modified 
cysteines C92 and C116, located within the well-folded N-terminal domain,  are not 
involved in Fe/S  cluster binding  according to the not-observed interaction between the N-
terminal and CIAPIN1 domain (see second section of Results). 
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Figure 5. Identification of the cysteine residues involved in the Mia40-induced oxidation. 
Overlay of MALDI-MS spectra of anamorsin before (light green) and after (dark green) reaction 
with Mia40. The cysteine residues were carboxyamidomethylated with  IAM before proteins were 
subjected to SDS-PAGE and in-gel digested by chymotrypsin.  Schematic representation of the 
alkylation pattern of the cysteine residues of the CIAPIN1 domain before (light green) and after 
(dark green) reaction with Mia40. (see also Table S1).  
 
 To confirm this finding  on  the  coordination  mode  of  the  2Fe2S cluster, we 
produced a construct without  the last four cysteine residues which are oxidized by Mia40. 
The UV/vis and EPR spectra of this construct showed the same features of the full-length 
anamorsin (Fig. 6A and 6B), in agreement with the participation of the CX8CX2CXC 
motif in 2Fe2S cluster binding as shown by the MALDI-MS analysis.  In this construct, the 
presence of a 2Fe2S cluster was also confirmed through ESI-MS analysis. The molecular 
weight difference between 2Fe2S-anamorsin and apo-anamorsin is 175.78 which 
corresponds with the mass of 2Fe and 2S atoms (Fig. 6C). 
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Figure 6. Spectral features of the Fe/S cluster of the full-length and C-terminally truncated 
anamorsin are similar.  (A) UV-visible (50 mM Tris pH 8, 500 mM NaCl, 5% Glycerol) and (B) 
EPR spectra (200 µM, 50 mM Tris pH 8, 500 mM NaCl, 10% glycerol) of the C-terminally 
truncated  (solid line) and full-length  2Fe2S-anamorsin (dashed line). EPR conditions where the 
same like in Fig. 3. (C) Overlay of the ESI-MS spectra of C-terminally truncated 2Fe2S-anamorsin 
(grey shaded) and  after addition of 0.025% formic acid  (black). The C-terminally truncated  apo 
form (MW 29566.22) was  formed  by acidification. The relative abundance was scaled with 
respect to the peak corresponding to the MW of C-terminally truncated 2Fe2S-anamorsin. 
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Solution structure of the N-terminal domain of anamorsin 
 
 The construct comprising the well-folded N-terminal domain (aa 1-172) features 
essentially homogeneous heteronuclear relaxation properties, with a few exception. The 
correlation time for overall protein tumbling, as estimated from the R2/R1 ratio, is 10.82 ± 
0.77 ns, as expected for a protein of this size in a monomeric state. Average 
15
N R1, R2, 
and 
15
N{
1H} NOEs values of 1.22 ± 0.13  s-1, 14.70 ± 1.98  s-1  , and 0.76 ± 0.09 are 
obtained, respectively, excluding residue 1-2 and 161-172, which have low or negative 
15
N{
1
H}  NOEs  values and are characterized by fast motions on the ns-ps timescale. Also 
the region between residues 102-107 shows a certain degree of motions on the same 
timescale as shown by values lower than the mean R2/R1 ratio (Fig. S4). 
 The solution structure of the above construct, solved by NMR, shows five α-helical 
and six β-strand alternated structural elements (Fig. 7). The β-strands are all parallel, 
except for the last which is antiparallel, forming a sheet around which the α-helices are 
arranged (Fig. 7). This fold resembles the core fold of S-adenosyl-L-methionine (SAM)-
dependent methyltransferases. The order of the β-strands in these proteins is generally 
3214576 which is also found in the N-terminal domain of anamorsin with the exception 
that the third β-strand is absent. In addition, the fold of anamorsin diverges from SAM-
dependent methyltransferases in the lack of the second α-helix and in the insertion of an α-
helix between the two last β-strands. The glycine-rich motif in the loop between the first β-
strand and first α-helix, which is typically responsible for the binding of the co-factor SAM 
in such methyltransferases is not conserved in the N-terminal domain of anamorsin 
(Fig. 7).
54,55,56
  These structural differences suggest that the N-terminal domain of 
anamorsin is not involved in SAM-binding, as indeed experimentally verified through 
1
H-
15
N HSQC spectra  by incubating the 
15
N-labeled N-terminal domain with a large excess of 
SAM molecule, but it is probably involved in partner recognition.  
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Figure 7. Solution structure of the N-terminal domain of anamorsin.  (A)  Ribbon 
representation of the 20 conformers with the lowest energy. α-helical structural elements are 
colored in red while β-strands are colored in cyan. The numbering of the secondary structure 
elements follows the arrangement in the typical SAM-dependent methyltransferase fold (αx: alpha-
helix insertion in the N-terminal domain of anamorsin). (B)  Section of the overlay between the 
structures of the N-terminal domain of anamorsin (grey) and the structurally closest 
methyltransferase  (blue,  BH2331  of  Bacillus halodurans). The typical glycine-rich loop involved 
in SAM binding in methyltransferases is shown (glycine residues of B. halodurans’ 
methyltransferase in red). The corresponding loop of anamorsin does not have any analogous 
glycine residues, but only glycine residues in helix α1 and beta-strand β4 in the shown section (in 
yellow). (see also Fig. S4 and Table S2). 
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 The human anamorsin protein is formed by a SAM-dependent methyltransferase-
like structural domain but with no co-factor SAM-binding activity, and a long unstructured 
and flexible Cys-rich region. Bioinformatic sequence analysis shows that the latter motif is 
highly conserved and part of a large eukaryotic protein family (with members ranging from 
basal protozoa to fungi, higher plants and animals, up to humans). This Cys-rich motif of 
anamorsin is involved in the binding of a 2Fe2S cluster through the first four cysteines of 
the motif, i.e. CX5-14CX2CXC, defining  a novel cysteine-binding motif for Fe/S proteins, 
as  shown by an extensive characterization performed through NMR, UV-vis, EPR and 
both ESI-MS and MALDI-MS analysis. This feature is different from  the yeast homologue 
Dre2 that has been proposed to bind a 4Fe4S cluster in addition to a 2Fe2S cluster, based, 
however, only on EPR data, which, as also mentioned by the authors, need further detailed 
investigation to be fully interpreted.
11,57
  
 It is being increasingly recognized that the intermembrane space plays a pivotal role 
in the coordination of mitochondrial activities with other cellular processes.
57
   Proteins of 
the IMS are particularly relevant for the coordinated exchange of components/signals into 
and out the mitochondria. One of these processes is represented by the connection of the 
Fe/S protein biogenesis machinery present in the mitochondrial matrix with the cytosolic 
one, but still not all of the involved proteins are known neither the exact pathways. Up to 
now, only one component, an ABC membrane transporter, located in the mitochondrial 
inner membrane, is found to be involved in exporting from the matrix a yet unidentified 
product of the ISC assembly pathway which is essential for the extra-mitochondrial Fe/S 
protein production.
58,59,60
   The orientation of the ABC transporter in the mitochondrial 
inner membrane, with its C-terminal nucleotide-binding domain in the matrix, predicts that 
it functions in the export of substrate from the matrix to the intermembranous space.
61
   
This export reaction is further facilitated by the presence of the sulfhydryl oxidase 
Erv1/ALR in the IMS and glutathione.
9,10
   On the basis of its protein IMS localization, the 
yeast homologue of anamorsin, Dre2, has been proposed to play a functional role in the 
assembly process of cytosolic Fe/S clusters once imported in the IMS, i.e. to generate a 
component or signal that is permissive for the subsequent assembly steps in the 
cytoplasm.
11
   In addition, it has recently been suggested a working model which involves 
Dre2 as a cytosolic electron donor necessary for the Fe/S cluster incorporation into 
cytosolic CIA proteins, by receiving the electrons from the diflavin reductase Tah18.
12
   
Results-Anamorsin 
77 
 
The cytosolic Dre2-Tah18 protein interaction has also been proposed to be implicated in 
controlling mitochondrial integrity and cell death after oxidative stress through a still 
unknown mechanism which, however, implies the mitochondrial relocalization of Tah18.
13
   
The cytosolic electron transfer pathway involving Dre2 and Tah18 seems also to be 
conserved in humans as the human homologues, anamorsin/CIAPIN1 and Ndor1, can 
functionally replace their yeast counterparts and interact with each other.
12
  
 Our data show that anamorsin interacts with a well-known mitochondrial oxidase, 
Mia40. In particular, Mia40 is able to specifically catalyze the formation of two disulfide 
bonds which involve the four cysteines of the twin CX2C motif. The latter is indeed not 
involved in iron-binding and is located at the C-terminus subsequent to the Cys-motif 
involved in Fe/S cluster-binding. Typically, mitochondrial proteins are directed to the IMS 
by internal cysteine-containing targeting signals that allow passage through the import 
TOM translocase.
15,45
    The cysteine residues in these signals (usually CX3C, CX9C motifs  
but also CX2C motifs)  are recognized by the IMS-localized oxidoreductase Mia40 which 
serves as an intramitochondrial import receptor and traps substrate proteins within this 
compartment by forming disulfides and  inducing folding.
15
  These IMS-targeted proteins  
are indeed unfolded before import and interaction with Mia40.  Our interaction data with 
Mia40 suggests that also anamorsin could in this way be transported into and retained in 
the IMS. Consistent with this proposal we have also found that i) the CIAPIN1 domain is 
completely unfolded,  similarly to  the typical CX3C and CX9C Mia40-substrates, and 
therefore is structurally appropriate to be imported into  the  IMS through  the  TOM 
channel and be recognized by Mia40, ii) the Mia40-dependent disulfide bond formation 
does not interfere with  the cluster formation,  indicating that the insertion and the presence 
of the Fe/S cluster within the IMS could be possible  in order  to  perform  an electron 
transfer functional role. The latter feature is also found in the mitochondrial copper 
chaperone Cox17, which is involved in the assembly of the copper centers of cytochrome c 
oxidase.
62
   Cox17,  similarly to  anamorsin,  undergoes  indeed formation of two disulfide 
bonds  between a  twin  CX9C  motif  by Mia40, while two additional cysteines, involved 
in copper binding and positioned upstream of the twin CX9C motif, as found for the Cys 
motif involved in Fe/S cluster-binding, are not oxidized by Mia40, thus being capable to 
coordinate the copper(I) ion.
63
   The fact that  the cluster assembly in yeast Dre2 is 
independent of the cytosolic CIA components is also in agreement with a possible cluster 
maturation reaction in Dre2 being operative not only in the cytoplasm but also in other 
compartments such as the IMS.
12
   Moreover, the fact that the full-length, IMS-localized  
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and well-known Mia40 protein partner  Erv1  is specifically required for the maturation of 
Fe/S proteins  outside mitochondria suggests that  anamorsin,  since  being a Mia40-
substrate,  can be the target protein  that is  linking the Mia40/Erv1-dependent 
mitochondrial  protein  trapping  pathway  to the cytosolic  iron/sulfur cluster maturation 
process.  
 All the above considerations suggest that anamorsin can play a functional role 
linked to cytosolic Fe/S cluster biogenesis not only in the cytoplasm as recently reported,
12
 
but  also in the IMS once trapped there through  the Mia40-Erv1  pathway. A similar 
double functionality in different cellular compartments has been found for other IMS 
proteins such as the copper chaperone of superoxide dismutase (CCS) which, similarly to 
anamorsin, has both cytosolic and IMS localization playing the same function in both 
compartments and being trapped into the IMS through the Mia40/Erv1 machinery.
41,64
  
Other functions can however be associated with anamorsin molecules in the IMS, in 
particular related to  oxidative mitochondrial stress response. The yeast Dre2 cytosolic 
protein partner Tah18 is indeed relocalized to mitochondria upon oxidative stress to induce 
cell apoptosis and anamorsin has been found to be linked to apoptosis-related 
processes.
13,16
  Therefore, the IMS-localized anamorsin could be a component of the cell 
death program.  
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Fig. S1. Related to Figure 2. The C-terminal part of anamorsin is flexible and does not 
interact with the N-terminal domain. (A) Overlay of  
15
N{
1
H} NOE experiments recorded with 
(positive peaks in red, negative in orange) and without saturation (peaks are in blue). (B) The 
weighted-average chemical shift differences ΔHN between full-length anamorsin and the                    
N-terminal domain plotted against the amino acid residue number.  ΔHN is ([(ΔH)
2
  + (ΔN/5)2]/2)1/2, 
where ΔH and ΔN are chemical shift differences for 1H and 15N, respectively. 
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Fig. S2. Related to Figure 3. Spectral features of anamorsin after reaction with Mia40  
UV/vis  (A)  and EPR  (B)  spectra  of 2Fe2S-anamorsin  after reaction with Mia40.  EPR 
conditions were the same like in Fig. 3 except that 10 mM dithionite was used for reduction of  
the cluster. 
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Fig. S3. Related to Figure 4. Backbone chemical shift variations and stability of 2Fe2S- 
anamorsin upon Mia40 addition 
(A) Overlay of 1H-15N HSQC spectra  (800MHz, 298K) of 15N-labeled 2Fe2S-anamorsin in the 
presence of 0 (blue) and 1.2 equivalents (red) of unlabeled Mia403S-S. A selected region of the 
spectra between 8 and 8.5 ppm reporting chemical shift changes of Gly residues is shown in detail.  
(B)  17% SDS PAGE  showing  the stability of  anamorsin before  (-) or after (+) reaction with 
Mia40 over 12 days. 
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Fig. S4. Related to Figure 7. 
15
N relaxation parameters R1, R2, 
15
N{
1
H} NOE and 
15
N R2/R1 
ratio versus residue number of anamorsin at 600 MHz and 298K.  
The protein was in 50 mM phosphate buffer pH 7.0, 2 mM DTT containing 10% (v/v) D2O. 
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Table S1. Related to Figure 5. Correlation between the masses and the corresponding 
peptides of anamorsin before and after reaction with Mia40 
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Table S2. Related to Figure 7. NMR and refinement statistics for the N-terminal domain  
of anamorsin 
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Glutaredoxins (GRX) are redox proteins widely present in both prokaryotes and eukaryotes 
which share the thioredoxin fold and use glutathione as a cofactor. These proteins are 
divided into two classes; monothiol (C-G-F-S), and dithiol (C-P-Y-C) on the basis of the 
presence of one or two cysteines in the highly conserved active sites. Whereas dithiol GRX 
have been characterized as reducers of disulfides (protein-S-S) or glutathione mixed 
disulfides (protein-S-SG) thereby serving important roles in redox homeostasis and signal 
transduction, the mechanism and function of monothiol GRX remain puzzling. 
 In each class, several crystal structures of GRX have been shown to form [2Fe-2S] 
cluster coordinating homodimers or tetramers (dimmer of dimers). The dithiol GRX 
homodimer is proposed to serve as a sequestration form and its iron-sulfur cluster as an 
oxidative stress sensor. In contrast, the monothiol GRX homodimer has been suggested to 
act as a scaffold for [2Fe-2S] cluster delivery.
1
 The discovery that a wide variety of 
recombinant monothiol GRXs can be purified containing [2Fe-2S] cluster under anaerobic 
conditions and that the cluster can be reconstituted on apo-forms in the presence of 
glutathione, has raised the possibility that they may function in the assembly, storage, or 
transfer of [2Fe-2S] clusters, or as sensors of the cellular Fe-S cluster status.
2
 Monothiol 
glutaredoxins coordinating the Fe-S cluster, bind non covalently the GSH molecule, which 
is required together with the active site cysteine in the CGFS motif for cluster assembly. 
The cluster is coordinated at the subunit interface by one cysteine from each GRX and two 
glutathiones. 
 A series of recent papers indicate that the recombinant versions of plant, yeast and 
human GRX5 orthologues (belonging to the monothiol subfamily) overexpressed in               
E. coli are able to incorporate labile Fe–S clusters.1,3 Yeast monothiol GRX5 has been 
shown to be a member of mitochondrial iron sulfur cluster assembly machinery (ISC). The 
protein plays a role in cluster delivery to the apo-recipients.
4,5
 Furthermore, 
complementation experiments of the yeast GRX5 deletion strain demonstrated that most 
CGFS monothiol GRXs from prokaryotic or eukaryotic sources other than yeast, when 
targeted to the yeast mitochondrial matrix, can functionally substitute for GRX5, 
suggesting that this role might be conserved throughout evolution.
6,7
 It has been 
demonstrated that GRX5 interacts in vivo with Isa1 and Isa2 proteins (both mitochondrial 
proteins involved in  Fe-S cluster delivery to the apo-proteins) by observing bimolecular 
fluorescence complementation. These results suggest that GRX5 plays a central role in         
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Fe-S assembly process through the interaction with previously mentioned A-type Fe-S 
scaffold proteins (Isa1 and Isa2), each of which is necessary for the proper function of 
mitochondrial ISC assembly machinery.
8
 
 Human glutaredoxin5 (GLRX5) is a monothiol glutaredoxin harbouring the 
conserved CGFS active site motif. Besides the cysteine in the CGFS motif, human GLRX5 
possesses another cysteine residue at the C-terminal part of the protein. GLRX5 like its 
yeast homologue is localised in the mitochondria where it is involved in the synthesis 
and/or transfer of iron-sulfur clusters to apo-proteins.
9
 It was shown that this member of 
the mitochondrial ISC assembly machinery functions downstream of ISCU. After a 
transient Fe-S cluster has been assembled on the ISCU scaffold, it must be transferred and 
incorporated into apo-proteins by coordinating with specific amino acid ligands. This 
process in human mitochondria is specifically assisted by the group of chaperon proteins 
including e.g. GLRX5, ISCA1/2 (homologues of yeast Isa1/2) and recently reported Ind1 
(responsible for cluster delivery to mitochondrial respiratory complex1).
10,11
 However, the 
exact molecular function of GLRX5 is still unclear. Deletion experiments in model 
organism S. cerevisiae showed that, mutant lacking GRX5 is highly sensitive towards 
oxidative stress, accumulates iron in the cells and causes inactivation of Fe-S cluster 
containing enzymes. A knock out of the zebrafish Shiraz GRX5 homologue causes 
hypochromic anemia due to impaired Fe-S assembly and as a result defects the haem 
biosynthesis. In humans a mutation that causes a splicing defect in GLRX5 is implicated as 
a cause of sideroblastic anemia.
12
 This example shows that Fe-S cluster biogenesis is 
directly connected with the overall cellular iron homeostasis.   
 Recombinantly expressed and purified human GLRX5 coordinates a [2Fe-2S] 
cluster similar to other monothiol glutaredoxin proteins.
13,14,15,16
 The crystal structure of a 
tetrameric form of human GLRX5 has been solved showing that iron-sulfur clusters is 
coordinated by two glutathione molecules and one cysteine of the active site from each 
subunit of the tetramer (2WEM). In this work we have structurally characterized human 
Glutaredoxin 5 in solution and its iron-sulfur binding properties were investigated through 
UV-vis and paramagnetic NMR spectroscopies. The data indicate that human GLRX5 
binds a [2Fe-2S] cluster in GSH dependent mode in a monomeric state, in contrast with 
what was found in the crystal structure. This suggests that the C-terminally located 
cysteine which is conserved in GLRX5 homologues is an additional Fe-S cluster ligand. 
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Bioinformatic tools 
 
The mitochondrial targeting signal located in the N-terminal part of GLRX5 
sequence was identified by the TargetP and SignalP online tools.
17
 The folding probability 
was predicted by the algorithm FoldIndex.
18
  Homologue sequences to GLRX5 were 
searched via Blastp (www.ncbi.nlm.nih.gov/BLAST/), and aligned using ClustalW 
(www.ebi.ac.uk/clustalw/). 
 
Molecular cloning expression and purification of glutaredoxin5 
 
The DNA encoding mitochondrial version of GLRX5 was amplified by PCR 
reaction using specific primers: Sense: CAC CAT GGG CGC GGG CGG CGG CGG C; 
Anti sense: CTA CTA TTC ATC TAA AAG GGC GGA GTG GAT CCC C, and 
subsequently cloned into pETG20A vector using the Gateway technology (Invitrogen), in 
order to obtain a plasmid producing the protein fused with N-terminal 6xHis-Trx tag. The 
vector was transformed in BL21 GOLD E.coli strain (Novagen) and cells were grown in 
LB media at 37° C under vigorous shaking overnight, diluted 1:1000 into LB or minimal 
medium (with 
15
(NH4)2(SO)4 as the nitrogen source) containing 100ug/ml ampicillin until 
OD at 600nm reached 0.6. Then, protein expression was induced by adding 1 mM IPTG.  
In order to produce a recombinant protein containing Fe-S cluster cells were grown 
in presence of 250 μM FeCl3. Expression was performed at 25° C for 14-16 hours. Cells 
were harvested by centrifugation at 6000 x g and resuspended in degassed lysis buffer (50 
mM Tris-HCl pH 8.0 containing 500 mM NaCl, 10 mM Imidazole and 5 mM GSH). Cells  
disruption was performed on ice by sonication alternating 30 seconds of sonication and              
5 minutes of resting for 10 times. All the following purification steps were performed 
under anaerobic conditions.  The soluble extract, obtained by ultracentrifugation at 40000 x 
g, was loaded on a HiTrap chelating HP column (GE Healthcare) previously charged with 
Ni
2+
 (for selective His-tag binding) and equilibrated with lysis buffer. After washing the 
column with different step corresponding to different, intermediate imidazole 
concentrations (W1 10 mM and W2 40 mM, Fig. 3), recombinant fused protein was eluted 
with 50 mM Tris-HCl pH 8.0 containing 500 mM NaCl, 5mM GSH and 500 mM 
imidazole (E, Fig. 3). The protein was then concentrated with an Amicon Ultra-15 
Centrifugal Filter Units with a MwC of 3kDa (Millipore). Cleavage of the tag was 
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performed by TEV protease (3ul TEV/1 mg GLRX5) in 1X TEV Buffer (50 mM Tris-HCl, 
pH 8.0, 0.5 mM EDTA, 5 mM GSH and 1 mM DTT) at room temperature with overnight 
incubation. The tag and the TEV itself (that present a His-tag at the N-terminus), were then 
removed from the cut protein by reverse affinity chromatography. Protein expression level 
and purity was monitored by SDS-PAGE electrophoresis. GLRX5 was used directly for 
analysis or flash-frozen in liquid nitrogen and stored at -80°C. 
 
Analytical gel filtration 
 
The aggregation state of apo- and holo-glutaredoxin5 was analyzed using analytical 
gel filtration approach. Purified samples were run on ÄKTAFPLC™ (GE Healthcare) 
using SuperdexTM 75 HR 10/30 analytical column (Amerscham Bioscience). In both cases 
degassed 50 mM Tris-HCl buffer pH 8.0 (containing 5 mM GSH, 500 mM NaCl) was used 
as an eluent with the flow rate of 0.5 ml/min.  
 
Iron and Sulfide quantification 
 
Iron concentration of purified samples of GLRX5 was estimated by using iron 
chelator bathophenanthrolinedisulfonic acid disodium salt (BPS) colorimetric assay
19
 and 
by ICP measurements. In the case of the colorimetric assay 350 µl of each sample dilution 
were treated with 50 µl of 5 % SDS for 5 minutes and later reduced with 50 µl of 10 mM 
sodium dithionite followed by addition of 50µl of 10mM BPS. Samples were incubated in 
dark for 20 minutes, mixed and centrifuged for 5 minutes at 12000 x g. Later absorbance at 
515 nm was measured and concentration was estimated by plotting the obtained values on 
the standard curve prepared with different concentration (0 - 100 µM) of ferric ammonium 
sulfate NH4Fe(SO4)2. Sulfide content of purified protein was determined by the 
colorimetric assay.
20
 Samples (600 µl of several sample dilutions in water) were treated 
with 50 µl of 6 % NaOH and incubated for 5 minutes. Samples were mixed with 125 µl of 
0.1 % DPD (N,N-dimethyl-p-phenylenediamine dihydrochloride, Sigma-Aldrich) (1 mg 
DPD  dissolved  in  1 ml  5 N HCl) followed by addition of 50 µl of 11.5 mM  FeCl3 
(dissolved in 1.2 M HCl) and incubated for 30 minutes at room temperature. Sulfide 
concentration was estimated by plotting absorbance values (recorded at 670 nm) on the 
standard curve generated from different concentrations of (0 - 100 µM) sodium sulfide 
Na2S. 
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UV-visible spectroscopy 
 
In order to identify the Fe-S cluster type coordinated by GLRX5 freshly purified 
protein samples were analyzed by UV-vis spectroscopy technique. Spectra were recorded 
using Cary 50 Eclipse Spectrophotometer, for samples in degassed 20 mM Ammonium-
acetate buffer pH 7.5. Spectra were recorded in the range between 250 and 750 nm. The 
stability of the cluster after exposure to air was checked by the same technique. 
 
Mass spectroscopy 
 
MALDI-MS experiments were performed on Bruker Daltonics Ultraflex III 
MALDI TOF/TOF instrument in order to confirm the molecular mass of the expressed and 
subsequently purified protein. 1 µl of protein solution was mixed with a 1 µl of matrix 
solution (SA 10 mg/ml in 70 % acetonitrile/30 % water, 0.1 % TFA) and analysed. Flex 
Control 3.0 was used as data acquisition software in positive linear mode. The instrument 
was externally calibrated prior to analysis using the Bruker Protein I calibrant standard kit 
(5000-17 000 Da). 
ESI/LTQ-Orbitrap high resolution mass spectrometer (Thermo Electron 
Corporation) was used for mass analysis. Mass spectra of GLRX5 were recorded using 
ammonium-acetate buffer pH 7.5 as a solvent. ESI-MS data were acquired in positive ion 
mode, setting the spray voltage at 5 kV, the capillary voltage and temperature respectively 
at 45V and 37° C, and the tube lens at 230V. For acquisition, Xcalibur 2.0 software 
(Thermo) was used and monoisotopic and average deconvoluted masses were obtained by 
using the integrated Xtract tool. For spectra acquisition a nominal resolution (at m/z 400) 
of 100.000 was used. 
 
Paramagnetic 
1
H-NMR 
 
 Cluster characterization was performed using 
1
H paramagnetic NMR. The spectra 
of 2 mM oxidized [2Fe-2S]-GLRX5 (50 mM phosphate buffer pH 7.0 with 10% D2O, 5 
mM GSH and 1 mM DTT) were recorded on a Bruker Avance 600 MHz spectrometer 
equipped with a selective 
1
H probe head (5 mm SEL 
1
H) at 298 K. Spectra of the 
paramagnetic signals were acquired with a recycle delay of 50 ms and an acquisition of 82 
ms. The 1D spectra, each acquired with 2048 scans, were summed to obtain the final 
spectrum. 
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GLRX5 – relaxation time measurments  
 
 For Apo-GLRX5 nine experiments were collected to measure the 
15
N R1 relaxation 
rates, with recovery delays of 10, 70, 200,380, 550, 740, 1000, 1350, 2500 ms. Ten 
experiments were collected to measure the 
15
N R2 relaxation rates using delays of 16.96, 
33.92, 67.84, 101.76, 135.68, 169.6, 203.52, 271.36, 305.28, 356.16 ms. All the data points 
were collected using 8 scans and with a recycle delay of 3 s.  
 For Holo-GLRX5 ten experiments were collected to measure the 
15
N R1 relaxation 
rates, with recovery delays of 10, 70, 150, 200,380, 550, 740, 1000, 1350, 3000 ms. Eleven 
experiments were collected to measure the 
15
N R2 relaxation rates using delays of 16.96, 
33.92, 67.84, 101.76, 135.68, 169.6, 203.52, 237.44, 271.36, 305.28, 356.16 ms. All the 
data points were collected using 8 scans and with a recycle delay of 3 s. The spectra 
parameters are reported in the Table 1. 
 For both apo- and holo- protein 
15
N{
1
H}NOEs were measured using 80 scans and 
acquiring two spectra: one with 
1
H saturation and one without.  The 
1
H saturation was 
maintained for 5.5 s. Spectra parameters are reported in Table 1. All the spectra were 
processed using the standard Bruker software (XWINNMR). 
 
Table 1. Acquisition parameters for NMR experiments performed at 298 K. 
 
Experiments 
 
Dimension of acquired data (nucleus) 
 
Spectral width (ppm) 
 
t1 t2 F1 F2 
1
H-
15
N-HSQC
 
200 or 256 (
15
N) 2048(
1
H) 14.0 34.0 
15
N R1
 
200 (
15
N) 2048(
1
H) 14.0 34.0 
15
N R2
 
200 (
15
N) 2048(
1
H) 14.0 34.0 
15
N{
1
H}NOEs
 
200 (
15
N) 2048(
1
H) 14.0 34.0 
 
 
Relaxation rates R 1 and R 2 were determined by fitting the cross-peak intensities measured 
as a function of the delay within the pulse sequence to a single-exponential decay. Errors 
on the rates were estimated through a least-squares method. The heteronuclear NOE values 
were obtained from the ratio of the peak intensity for [
1
H]-saturated and unsaturated 
spectra. Integration of cross-peaks for all spectra was performed using a standard routine of 
CARA software package. 
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 The overall rotational correlation time values were estimated from the R 2/R 1 ratio 
using the program QUADRATIC_DIFFUSION (G.A. Palmer III, Columbia University).
21
 
In this analysis, care was taken to remove from the input relaxation data those NHs having 
an exchange contribution to the R2 value or exhibiting large-amplitude internal motions on 
a time scale longer than a few hundred picoseconds, identified from low NOE values, as 
inclusion of these data would bias the calculated tumbling time.
22,23
  
 Theoretical prediction of the reorientation tumbling rate was also estimated using 
the available structures with the ―shell modeling‖ approach implemented in HYDRONMR 
software. The calculation was performed by using a viscosity of water at 298 K or 308 K 
of 8.9E-04 or 7.1 E-04 Ns/m
2
, respectively.
24
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Bioinformatic analysis of human GLRX5 
 
 Mitochondrial precursor of human glutaredoxin 5 is a 157 amino acid residues 
protein, containing a mitochondrial targeting signal in the N-terminal part of the 
sequence.
17
 This peptide signal is cleaved upon protein maturation in the targeted 
compartment. On the basis of bioinformatic anlalysis, we cloned a GLRX5 construct where 
the N-terminal 34 residues constituting the targeting signal were removed together with the 
last seven residues from C-terminal part, which were not present in the crystal structure 
(PDB 2WEM) and therefore highly unstructured. Obtained construct comprised residues 
35-150.  
 GLRX5 sequence was analysed with folding prediction tools – IndexFold and 
Phyre server.
18,25 
No disordered regions were found (Fig. 1) and the protein was predicted 
to have thioredoxin-like fold. Blast search and alignment also showed that the cysteine 
(residue 67) from the CGFS motif is conserved among eukaryotic homologues. Moreover, 
another cysteine (residue 122) is conserved at the C-terminus (Fig. 2). 
 
 
 
 
Figure 1. (A) Folding prediction of investigated construct of GLRX5 derived from FoldIndex 
program. Regions shaded in green are predicted to be in a folded state, while red shaded regions are 
predicted to be unfolded. (B) Sequence of expressed construct of GLRX5 (residues 35-150 of the 
mitochondrial precursor).  
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Homo_sapiens                  -----MSGSLGRAAAALLRWGRGAGGGGLWGPGVRAAGSGAGGGGSAEQL 
Rattus_Norvegicus             -----MSASLSRAAAALLRWGRGAGGGVLPRAGVRAASS----GGQAEQL 
Bos_taurus                    -MSGSLGRAAATAASALLRWGRGAGGG-LRGPGVRAAGS--GGSGSSEHL 
Gallus_gallus                 MSGSLRAALRLGVWAARGRPGRRHLSEAASGSAGGSGGADGGGSGSREAV 
Xenopus_laevis                -----MSWCLSKVSAAVLRGSARTPQACGSLSVLRWLSSD---SVSPEHL 
Danio_rerio                   -----MNSVFRSTARCLRSATWQYKTAHKNGELSVGRARLMCSSAGQKNL 
Saccharomyces_cerevisiae      ------MFLPKFNPIRSFSPILRAKTLLR------YQNRMYLSTEIRKAI 
Candida_albicans              --MFRRSLLSTSRFINKSSSSLSPGLLLNNFR-GNFQQSRFISTELKDAL 
Neurospora_crassa             --MLTRSLFSRQLFAAASRPAIAPKAVSSAFRPVLFYQNRFLSDATRQAI 
                                                                              
 
 
Homo_sapiens                  DALVKKDKVVVFLKGTPEQPQCGFSNAVVQILRLHGVR--DYAAYNVLDD 
GLRattus_Norvegicus           DALVKKDKVVVFLKGTPEQPQCGFSNAVVQILRLHGVR--DYAAYNVLED 
Bos_taurus                    DALVKKDKVVVFLKGTPEQPQCGFSNAVVQILRLHGVR--DYAAYNVLDD 
Gallus_gallus                 ERLVREHPVVVFMKGSPAQPLCGFSNAVVQILRLHGVE--DYRAHDVLQD 
Xenopus_laevis                DGLVKKDKVVVFIKGTPAQPMCGFSNAVVQILRMHGVN--DYAAYNVLED 
Danio_rerio                   EEMVKKDKVVVFMKGTPAQPMCGFSNAVVQILRMHGVD--NYASYNVLDD 
Saccharomyces_cerevisiae      EDAIESAPVVLFMKGTPEFPKCGFSRATIGLLGNQGVDPAKFAAYNVLED 
Candida_albicans              DKAVTTSPVVLFMKGTPEFPQCGFSRATIQILGQQGVDPEKFAAYNVLED 
Neurospora_crassa             DKAVASAPVVLFMKGTPETPQCGFSRASIQVLGLQGVDPNKFAAFNVLED 
                                      ** * ** *  * **** *    *   **         ** * 
 
 
Homo_sapiens                  PELRQGIKDYSNWPTIPQVYLNGEFVGGCDILLQMHQNGDLVEELKKLGI 
GLRattus_Norvegicus           PELRQGIKDYSNWPTIPQVYLNGEFVGGCDILLQMHQNGDLVEELKKLGI 
Bos_taurus                    PQLRQGIKDYSNWPTIPQVYLNGEFVGGCDILLQMHQNGDLVEELKKLGI 
Gallus_gallus                 PDLRQGIKNYSNWPTIPQVYLNGEFVGGCDILLQMHQNGDLVEELKKLGI 
Xenopus_laevis                QDLRQGIKNYSNWPTIPQVYFNGEFVGGCDILLQMHQNGDLVEELNKLGI 
Danio_rerio                   QDVRQGIKTFSNWPTIPQVFFNGEFVGGCDILLQMHQSGDLVEELQKLGI 
Saccharomyces_cerevisiae      PELREGIKEFSEWPTIPQLYVNKEFIGGCDVITSMARSGELADLLEEAQA 
Candida_albicans              SELREGIKEYSSWPTIPQLYVNGEFIGGCDIITSMAQNGELAELLEESNA 
Neurospora_crassa             AELRQGIKEYSDWPTIPQLYIDKEFVGGCDIIVSMHQNGELAKLLEEKDV 
                                 * ***  * ******     ** ****    *   * *   *    
 
 
Homo_sapiens                  HSALLDEKKDQDSK-------------- 
GLRattus_Norvegicus           RSALIDEK-DQDSK-------------- 
Bos_taurus                    RSALLDDTKDQDSK-------------- 
Gallus_gallus                 RSALLDAEKDQEKK-------------- 
Xenopus_laevis                RSALLDAEPSQEKK-------------- 
Danio_rerio                   RSALLDQEKESK---------------- 
Saccharomyces_cerevisiae      LVPEEEEETKDR---------------- 
Candida_albicans              LIPEENEPTTSEENQETVQSANIKPNRN 
Neurospora_crassa             LVKGEEGAAEEQTEKKE----------- 
                                    
 
 
 
Figure 2. Alignment of human glutaredoxin5 with homologue proteins from different 
organisms. The conserved active site motif (CGFS) is marked in red, second conserved 
cysteine residue located in the C-terminal part of the proteins is marked in yellow,                       
(*) indicates identity of residues among the species.  
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Expression and purification of GLRX5 
 
 Gene encoding the mature version (residues: 35-150) of GLRX5 was amplified by 
PCR reaction and inserted into the Gateway® pEntr-TEV-d-Topo vector (InvitrogenTM), 
followed by recombination with pETG20A destination vector and transformation into 
BL21 (DE3) Gold E.coli strain. Protein was recombinantly expressed and purified. Affinity 
chromatography purification employing the HisTag, performed without addition of GSH in 
anaerobic conditions lead to a soluble and pure apo-GLRX5. In order to obtain a holo-form 
of GLRX5, E.coli cells were grown in presence of 250 μM FeCl3. Subsequent anaerobic 
purification (in glove-box) using degassed buffers (in presence of 5 mM GSH) resulted in 
reddish-brown protein solution, that indicated a presence of bound cofactor. These data 
show that the binding of Fe-S cluster is strictly dependent from a presence of glutathione. 
After purification the protein was concentrated in presence of 5 mM DTT and the fusion 
protein was cleaved using TEV protease at room temperature, and removed by reverse 
affinity column. For both apo- and holo-GLRX5, the purity of the target protein was higher 
than 90%, judged from SDS-PAGE electrophoresis (Fig. 3).  
 
 
 
 
Fig 3. Purification of recombinant GLRX5. Recombinantly expressed in E.coli GLRX5 fused 
with thioredoxin tag (red circle), was applied on the Ni chelating column and subsequently purified 
(green circle). L – loading, FT – flow through, W1 – 1st washing step, W2 – 2nd washing step, E –
elution.  Purified fused target protein was digested with TEV protease and applied on the reverse 
affinity column. GLRX5 is a 13 kDa protein (blue circle). 
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The expected molecular weight (13157.9 Da) of the overexpressed apo-protein was 
confirmed by MALDI-MS (obtained value 13158,123 Da) and ESI-MS (obtained value 
13157.67 Da) analysis.   
The ratio between GRLX5:Fe:S in the holo-protein was estimated by using 
colorimetric assays (described in Materials and Methods). The iron content in the purified 
protein sample was also measured through ICP analysis. A GRLX5:Fe:S ratio of 1:2:2 has 
been achieved in all preparations.  
 
GLRX5 binds a [2Fe-2S] cluster 
  
In order to characterize the holo-GLRX5, UV-visible spectroscopy was performed. 
Samples were prepared in anaerobic chamber (in 20 mM ammonium-acetate buffer pH 7.5) 
and transferred to sealed cuvettes. Spectra were recorded in the range from 250-750 nm, 
showing the characteristic peaks of [2Fe-2S] cluster at 320 nm and 410 nm (Fig. 4).
26
     
 
 
 
Figure 4. UV-visible spectra of freshly purified GLRX5.  Presence of [2Fe-2S] cluster 
coordinated by GLRX5 was confirmed by UV-vis spectroscopy. Arrows on the spectra indicate 
peaks at 320 and 410 nm that are characteristic for [2Fe-2S] cluster.  
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 The stability of the bound Fe-S cluster after exposure to air was also monitored by 
UV-visible spectroscopy (Fig. 5). After exposure to air the intensity of spectra was 
decreased, indicating release of the cluster. After 12h in aerobic conditions these 
absorbances were quenched, indicating that the Fe-S cluster is coordinated in the labile 
fashion. 
 
Figure 5. Quenching of the typical peaks upon air exposure. Freshly purified sample (red trace), 
1 h air incubation (green trace), 3 h air incubation (blue trace), 6 h air incubation (violet trace), and 
12 h air incubation (black trace). Arrows indicate characteristic peaks of 2Fe-2S cluster. 
 
 Further cluster characterisation was performed through 1D paramagnetic NMR 
approach. Data obtained from 
1
H paramagnetic NMR also indicate a presence of [2Fe-2S] 
cluster bound by GLRX5. The spectrum of the oxidized protein recorded on 600 MHz 
magnet at 298K exhibited two broad peaks with maxima at 25 and 29 ppm (CHβ-Cys 
protons) and two sharp signals at 12 and 14 ppm (CHα-Cys protons) (Fig. 6). These signals 
were typical of proteins with [2Fe-2S] cluster.27,28,29 After anaerobic addition of 1 mM 
dithionite no paramagnetic signals were detected. We have interpreted this result as a 
consequence of fully release of the cluster, in agreement with the bleaching of protein 
solution. 
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Figure 6. 
1
H-NMR paramagnetic spectra of oxidized GLRX5 
Paramagnetic 
1
H- NMR spectrum of holo-GLRX5 (2 mM) in 50 mM phosphate buffer  pH 7.0 (in 
presence of 5mM GSH and 5 mM DTT) recorded at 600 MHz magnet and 298K. 
 
Glutaredoxin 5 coordinates [2Fe-2S] cluster as a monomer 
 
 It was recently reported that the CGFS-type monothiol Grxs from different 
organisms (cyanobacterium Synechocystis (SyGrx3p), E.coli (EcGrx4p)), exist as a dimeric 
iron-sulfur containing holo-proteins or as a monomeric apo-proteins in solution.
6,13
  
Following this information we decided to check if the human GLRX5 behave in the same 
manner. In order to answer this question we performed analytical gel filtration analysis of 
both apo- and holo-GLRX5. Samples were applied on the Superdex
TM
 75 HR 10/30 
column, equilibrated with degassed elution buffer in presence of 5 mM GSH and 5mM 
DTT. As described for cyanobacterium Synechocystis monothiol glutaredoxin (SyGrx3p) 
we expected to see a shift in the elution peaks corresponding to the monomeric (apo) and 
dimeric (holo) protein forms, but our experimental data were different.  Apo- and holo-
GLRX5 were indeed eluted at the same volume (13.5 ml) and consistently with the cluster 
being coordinated by a monomeric species (Fig. 7). 
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Figure 7. Analytical gel filtration of holo- and apo-GLRX5 (red and blue trace 
respectively).  
 
1
H-
15
N HSQC NMR experiments were then performed for both apo- and holo-
protein. We can observe chemical shifts changes between two GLRX5 forms, indicating 
that several residues are affected by GSH-dependent Fe-S cluster binding (Fig. 8).  
 
 
Figure 8. 
1
H-
15
N HSQC of the recombinant Glutaredoxin5 apo (red) and holo (black), 
Samples were used for the relaxation time calculations. 
 
1H 
15N 
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Backbone heteronuclear relaxation data can provide information on the overall 
protein tumbling rate which is strictly linked to the aggregation state of the molecule in 
solution. From the analysis of the well-resolved backbone HN signals on both apo and holo 
forms, average [
15
N] R 1,  R 2, and [
1
H–15N] NOE values of R1apo 1.68 ± 0.25, R2apo 
10.18 ± 2.32, R1holo 1.53 ± 0.18, R2holo 12.54 ± 3.46 s
−1
; [
1
H–15N] NOEapo 0.70 ± 0.27, [
1
H–
15
N] NOEholo 0.65 ± 0.38 are obtained, respectively. Both apo and holo forms feature 
essentially homogeneous heteronuclear relaxation properties. The correlation times for 
overall protein tumbling, as estimated from the R2/R1 ratios, are 7.53 ± 0.677 ns and 8.906 
± 0.856 ns for apo- and holo- protein, respectively. The tumbling times of both apo- and 
holo-GLRX5, experimentally estimated by heteronuclear relaxation data, are in agreement 
with that predicted through the HYDRONMR program at the same magnetic field and 
temperature. The latter have been calculated using the crystal structure of yeast and human 
apo-glutaredoxin 5 forms (9 ns and 8 ns). Therefore, these values are in agreement with a 
protein of this size (13 kDa) indicating that holo form is in a monomeric state as found for 
the apo form.  
 
 
 
 GRX5 proteins are mitochondrial monothiol glutaredoxins present in eukaryotes 
from yeast, plants to humans. Bioinformatic sequence analysis of human GLRX5  shows 
that the protein contain a conserved, for monothiol subfamily, CGFS motif in the N-
terminal part of the sequence, and another conserved, for GRX5 homologues only (not for 
all monothiol glutaredoxins) cysteine residue in the C-terminus. Several crystal structures 
of  dimeric and tetrameric (dimmer  of a dimers) forms of monothiol glutaredoxins 
(including human GLRX5) coordinating [2Fe-2S] cluster in the GSH dependent manner  
were reported.
13,30,
 These data showed that the cluster is coordinated by two glutathione 
molecules and one cysteine of the active site from each subunit of the homo-dimer. We 
recombinantly expressed in E.coli and characterized two forms (apo- and holo-) of human 
GLRX5 protein.  
 UV-vis and 1D NMR spectroscopy data indicated that holo-GLRX5 binds [2Fe-2S] 
cluster in the GSH dependent, labile fashion similar to other monothiols previously 
described in the literature. In contrast to the reported crystal structure of human GLRX5 
our aggregation state analysis, performed using analytical gel filtration and NMR 
relaxation studies, clearly showed that the GLRX5 in solution binds the cofactor as a 
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monomer. Therefore, we postulate that two conserved cysteines (residues 67 and 122) 
present in the sequence of the protein and GSH molecules can be necessary for the cofactor 
coordination. On this basis, two possible ways of cluster ligation are presented in the Fig. 
10.    
 
 
 
Figure 10. Two proposed models for [2Fe-2S] cluster coordination performed by human GLRX5.  
 
The distance between the conserved cysteine residues measured from the crystal structure 
of human GLRX5 indicate that model A (Fig. 10), in which cysteine residues coordinate 
two different iron ions, does not require large structural rearrangements to ligate the 
cofactor, in contrast with model B (Fig. 10) in which large conformational changes would 
be necessary for the cysteine residues to coordinate the same iron ion.  
In conclusion, our results suggest that the physiogical mitochondrial form of human 
GRLX5 contains a [2Fe-2S] cluster in a monomeric state. The latter form is best suited 
with respect to the tetrameric state to rapidly donate the Fe-S cluster to the protein partner, 
the recently identified ISCA1, ISCA2 proteins which are involved in the cluster insertion 
into mitochondrial Fe-S dependent enzymes. Protein-protein interaction studies between 
GRLX5 and ISCA1 or ISCA2 to follow Fe-S cluster transfer efficiency as well as to 
characterize the molecular recognition process are now in progress. 
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 P-type ATPases are a superfamily of membrane proteins, which are responsible for 
the active transport of a variety of cations across cell membranes. More than 200 P-type 
ATPases have been identified so far and they play critical roles in ion homeostasis in 
species as diverse as bacteria and humans. Translocation of cations against their 
electrochemical potential gradient is achieved by utilizing the energy of the hydrolysis of 
ATP.
1,2  
The human Cu-transporting P1B-type ATPases ATP7A and ATP7B (Menkes MNK 
and Wilson WLN proteins, respectively) are two key proteins that regulate the Cu status of 
the body. They transport Cu across cellular membranes for biosynthetic and protective 
functions, enabling Cu to fulfill its role as a catalytic and structural cofactor for many 
essential enzymes, and to prevent a toxic build-up of Cu inside cells.
3,4   
Mutations in genes 
encoding MNK and WLN proteins lead to Menkes and Wilson diseases, respectively (see 
also chapter 1).    
 The core structure of Menkes and Wilson proteins (that share ~60% amino acid 
identity) is composed of eight transmembrane helices and two soluble domains, the 
Actuator-domain (A) and the ATP-binding domain. The latter one is composed by two 
subdomains: the Phosphorylation-domain (P) and the Nucleotide-domain (N) which is an 
insert in the P-domain sequence. In addition, their long N-terminal tail contains six 
independently folded copper(I)-binding domains (MBD1-6) (Fig. 1).5  
 
 
Figure 1. Schematic diagram of the structure of the Cu-ATPases, ATP7A and ATP7B. 
Reprinted from La Fontaine et al., Journal of Biochemistry & Cell Biology (2010) 
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 These Cu-ATPases transport copper from the cytosol across cellular
 
membranes. 
The central step in the catalytic cycle is the binding of an ATP molecule by the N-domain. 
-phosphate is transferred from ATP to the invariant Asp residue in the DKTG
 
motif, 
located within the P-domain, resulting in the formation of a transient phosphorylated
 
intermediate. The prerequisite for this reaction is the binding
 
of copper to the sites within 
the membrane portion of the enzyme containing the conserved CPC motif,
 
while the 
release of copper from these sites stimulates the dephosphorylation of Asp performed by 
the conserved TGE motif located in the A-domain.
6,7,8
 During copper transfer, MNK and 
WLN P1B-type ATPases undergo large conformational changes. Originally, two distinct 
conformations were called E1 and E2 (enzyme-1 and enzyme-2) (Fig. 2), with each having 
a different affinity for the nucleotide and the transported ions.
4,7,9,
 
 
Figure 2. The simplified catalytic cycle of human Cu-ATPases. Two major conformational states 
associated with high affinity for ATP and Cu (E1) and lower affinity for these ligands (E2) as well 
as phosphorylated intermediates (E1–Pi–Cu and E2–Pi–Cu) are shown. 
 
 Several soluble domains of MNK and WLN proteins had been structurally 
characterized in our laboratory, followed by intermolecular and partner (human copper(I) 
chaperone) interaction investigations.
7,10,11,12,13
 Moreover, mutational studies were 
performed to get insights on the mechanism of protein copper-dependent translocation.
14
 
With the aim of structurally characterizing and understanding at the molecular level the 
interplay between the ATP-binding domain and N-terminal copper binding domain, I 
attempted to produce ATP-binding domains from both MNK and WLN proteins as well as 
the P-domain of MNK. 
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Bioinformatic tools 
 
 Sequences of ATP-binding domain from Menkes and Wilson proteins were aligned 
using the ClustalW program and default parameters. Folding prediction of MNK ATP-
binding domain and P-domain constructs was performed using FoldIndex© and PSI-PRED 
online bioinformatic tools.
15,16
 A 3D model of MNK ATP-BD was built based on multiple-
threading alignments by LOMETS and iterative TASSER simulations. The PDB entry 
3A1C was used as a template for modeling.
17,18
 
 
Cloning strategies 
 
 Investigated constructs:  
1. WLN ATP-binding domain (K1010-R1324),  
2. MNK ATP-binding domain (K1027-R1354),  
3. MNK ATP-binding domain (without helices)(K1037-D1337),  
4. MNK P-domain (K1027-T1050/fused with/V1232-R1354),  
5. MNK P-domain Ala (K1027-T1050/AlaAla/V1232-R1354),  
6. MNK P-domain without helices (K1037-T1050/fused with/V1232-D1337),  
7. MNK P-domain Ala without helices(K1037-T1050/AlaAla/V1232-D1337) 
 
 Genes encoding WLN (construct 1) and MNK (construct 2) ATP-binding domains 
were amplified from human cDNA using PCR and inserted into the Gateway® pEntr-TEV-
d-Topo vector (Invitrogen
TM
). The entry clone containing MNK ATP-binding domain 
(construct 2) was used as a template for the amplification of constructs 3,4,5,6 and 7. 
Primers for all the constructs were designed for Gateway Technology®. Constructs of 
MNK P-domain (4 and 5) were build-up by several rounds of PCR reaction in order to 
eliminate the sequence of the N-domain and fuse the C- and N-terminal part of the P-
domain. Two predicted alpha-helices from the C-terminal and N-terminal part of the MNK-
ATP and P-domain constructs (marked - without helices) were eliminated using PCR 
reaction.  
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Expression and purification 
 
 Positive clones of constructs 1 and 2 were subcloned into pDEST-17(6xHis), 
PTH34 (6xHis-Gb1), PETG-20A (TRX-6xHis), PETG-30A (6xHis-GST) and pDEST-
MBP (6xHis-MBP) destination vectors in order to perform expression test. Positive clones 
of constructs 3, 4, 5, 6, 7 were subcloned into destination vectors: pDEST-17(6xHis), 
PTH34 (6xHis-Gb1), PETG-20A(TRX-6xHis), PETG-30A(6xHis-GST). All the plasmids 
were transformed into Rosetta-2 (DE3), BL21 (DE3) pLysS and BL21 (DE3) gold E.coli 
strains. A series of expression and solubility tests were performed using: standard 
expression test (100 ml culture, IPTG concentrations: 1.0 - 0.25 mM and temperature: 37, 
25 and 17
o
C) for constructs 1 and 2. High-throughput expression and solubility test (5 ml 
cultures grew on 24-well plates induced with IPTG concentration of 0.5 mM at 37, 25 and 
17
o
C,) was performed for constructs 3, 5, 6 and 7. Samples were collected after 5-16 hours 
after induction and analysed by SDS-PAGE electrophoresis.  
 Soluble proteins were purified on nickel-charged HiTrap chelating HP column 
(Amersham Pharmacia Biosciences) followed by over-night TEV digestion and reverse 
Ni(II) affinity chromatography in order to remove the cleaved tag. Additionally, the 
amylose resin affinity chromatography column was employed in case of MBP fused 
proteins. Size exclusion chromatography on Superdex 75 Hi Load-16/60 column (GE 
Healthcare) was used as the final purification step. 
 In order to obtain sufficient amount of WLN ATP-binding domain fused with 
6xHisTag (expressed as inclusion bodies), bacterial cells were harvested after 5 h of 
induction (1 mM IPTG) at 37° C. Cells were resuspended in 50 ml of lysis buffer (50 mM 
Tris at pH 8, 150 mM NaCl, 1 mM EDTA, 0.1% Triton X100, 1 mM PMSF, 0.25 mg/ml 
lysozyme) and frozen overnight at -80°C. After thawing the cell suspension, DNAse and 
MgSO4 were added at final concentrations of 10 μg/ml and 20 mM, respectively. The 
lysate was incubated for 30 min at 37°C (or until it was no longer viscous), and then spun 
for 30 min at 17,000g. After discarding the supernatant, the pellet was thoroughly 
resuspended in 50 ml of Tris buffer (50 mM Tris at pH 8, 150 mM NaCl), disrupted by 
sonicating it four times with a 15-sec pulse, and spun again. This washing procedure was 
repeated three times. The final pellet was solubilized in 20 ml of 50 mM Tris, 150 mM 
NaCl, 10 mM imidazole, 8 M guanidinium chloride. After a 30-min run at 17,000g, the 
supernatant was loaded onto a HiTrap chelating HP column (Amersham Bioscience) 
preequilibrated with 50 mM Tris, 150 mM NaCl, 10 mM imidazole, and 8 M urea (buffer 
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A). The column was washed with buffer A supplemented with 40 mM imidazole, and the 
recombinant protein was eluted with buffer A containing 250 mM imidazole. Protein purity 
was checked by SDS-PAGE. Elution fractions containing the protein of interest were 
pooled, and the imidazole was removed using a desalting column. 
  
Refolding 
 
 In order to find the best conditions for refolding of 6xHisTag WLN ATP-binding 
domain, 27 different buffer compositions (Tris-HCll pH 8.0, phosphate pH 7.0 and 
ammonium-acetate pH 5.0, buffers with different NaCl and glycerol concentration) were 
tested using UV-visible spectroscopy to follow the precipitation by measuring solution 
turbidity at wavelength 340 nm.
19
 The best buffer conditions (the lowest absorbance), were 
scaled-up.  
 
Light scattering 
 
 Aggregation states of purified proteins were investigated by using 0.3 mM samples 
(100 μl) on a G2000SWXL  analytical column (Tosoh Bioscience) with a void volume of 
150 kDa. The column was connected with a multiangle light scattering device (DAWN-
EOS Wyatt Technologies, Santa Barbara, CA) coupled with quasi-elastic light scattering 
detectors. Data were analysed with Astra software (Wyatt Technology) to estimate the 
molar mass. 
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Wilson and Menkes ATP-binding domains 
 
  Wilson and Menkes ATP-binding domains (constructs 1 and 2, see materials 
and methods) were expressed as inclusion bodies in three different E.coli strains (Rosetta-
2(DE3), BL21(DE3) pLysS and BL21(DE3) gold) using several destination vectors 
(pDEST-17(6xHis), PTH34 (6xHis-Gb1), PETG-20A (TRX-6xHis), and PETG-30A 
(6xHis-GST)) during the standard expression test.  
 The only soluble expression was obtained using pDEST-MBP (6xHis-MBP) vector. 
The highest yield for both proteins was obtained by expressing the recombinant proteins in 
the BL21 (DE3) pLysS strain at 25° C using 0.5 mM final IPTG concentration. These 
conditions were scaled-up and extracted proteins after affinity chromatography purification 
were digested with TEV protease. Efficiency of cleavage was lower than 50%. Proteins 
were subsequently applied on reverse affinity column followed by amylose resin 
purification. Elution fractions from the amylose resin column contained cleaved and fused 
species. Further purification using the Gel filtration showed two peaks; one in the void 
volume of the column containing both cleaved and un-cleaved proteins and the second 
containing only MBP fusion. These results suggest that the WLN and MNK ATP-binding 
domains have high tendency to aggregate.  
 
Refolding of Wilson ATP-binding domain 
 
  Wilson-ATP binding domain fused with 6xHisTag (pDEST17 vector) was 
the subject of refolding condition screening. The protein was overexpressed in the 
BL21(DE3) pLysS E.coli strain at 37° C for 5 h in the presence of 1 mM IPTG and 
purified from inclusion bodies (IB). Refolding buffer conditions were screened by quick 
dilution method (with protein : buffer ratio equal 1:100) followed by precipitation analysis 
using UV-visible absorbance. The tested buffer conditions are presented in (Tab. 1). 
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Table 1. High-throughput buffer condition test. Three different 50 mM buffers (ammonium-acetate 
(pH 5.0), phosphate (pH 7.0) and Tris-HCl (pH 8.0)) were tested. The buffer with the lowest 
absorbance at 340 nm was chosen for the refolding scale-up (highlighted in yellow) 
  BUFFER NaCl [M] Glycerol   BUFFER NaCl [M] Glycerol   BUFFER NaCl [M] Glycerol 
1 pH 7.0 0 0% 10 pH 5.0 0,2 10% 19 pH 5.0 0,1 0% 
2 pH 8.0 0,2 0% 11 pH 5.0 0,2 0% 20 pH 8.0 0 10% 
3 pH 8.0 0,1 10% 12 pH 8.0 0 5% 21 pH 8.0 0,1 0% 
4 pH 5.0 0 5% 13 pH 5.0 0 0% 22 pH 5.0 0,1 10% 
5 pH 8.0 0,2 10% 14 pH 8.0 0,2 5% 23 pH 7.0 0,2 5% 
6 pH 7.0 0 10% 15 pH 8.0 0,1 5% 24 pH 7.0 0,1 5% 
7 pH 5.0 0 10% 16 pH 7.0 0,2 0% 25 pH 5.0 0,1 5% 
8 pH 5.0 0,2 5% 17 pH 7.0 0,2 10% 26 pH 7.0 0 5% 
9 pH 7.0 0,1 10% 18 pH 7.0 0,1 0% 27 pH 8.0 0 0% 
 
 Scaled-up refolding of the purified WLN ATP-binding domain was performed in 
anaerobic conditions (inert atmosphere chamber – Coy Lab) in an ice bath using multi-step 
dialysis against degassed solutions containing 50 mM Tris-HCl (pH 8.0), 0.2 M NaCl, 
decreasing concentrations of urea (8 – 0 M) and 5 mM DTT. Aggregation state analysis of 
the refolded sample (using analytical gel filtration approach - column G2000 SWXL) 
showed that the protein forms aggregates bigger than 150 kDa (only one peak in the void 
volume of the column). After 3-4 hours of incubation at room temperature all the protein 
precipitated. The addition of detergents (TritonX-100, PEG 3000), glycerol or Arginine 
during or/and after the refolding process did not inhibit the aggregate formation. 
 
Menkes ATP-binding and P -domain   
 
  P1B-ATPases are found in all kingdoms of life, from extremophilic archaea to man 
and despite of sequence differences they share a common basic core architecture. One of 
the common protein domains - the ATP-binding domain - is the large cytoplasmic loop 
located between the transmembrane helix 6 and helix 7. The domain encompasses two 
subdomains; the nucleotide binding (N) and the phosphorylation (P) domains. The P-
domain is the most conserved among all P1B-ATPases. Based on the homology (Fig. 3A) 
to the structurally characterized ATP-binding domain from the hyperthermophile 
Archaeoglobus fulgidus, namely CopA, which is a Cu
+
-ATPase that contains all of the key 
elements present in eukaryotic Cu
+
-ATPases, a 3D model of the MNK ATP-binding 
domain was created using the I-TASSER server (Fig. 3B) and new constructs of the 
Menkes ATP-binding domain were cloned. 
17,18,20
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Figure 3. (A) Sequence alignment between ATP-binding domains of CopA and MNK proteins. 
Barrels and arrows represent secondary structure components of the CopA ATP-binding domain. 
Residues comprising the P-domain are highlighted in blue. Asterisks (*) indicate conserved 
residues (homologues share 36% of identity). (B) On the left, crystal structure of ATP-binding 
domain of CopA from Archaeoglobus fulgidus (Reprinted from Sazinsky et al. JBC 2006). On the 
right, 3D model of ATP-binding domain of Menkes. N- and C-terminal α-helices eliminated during 
cloning of the new constructs of ATP binding and P-domain are marked with arrows. 
 
  
 
 
Results - Wilson & Menkes proteins 
116 
 
In order to increase the solubility of the recombinantly expressed MNK ATP-
binding domain, two α-helices (one from the C- and the other from the N-terminus, helices 
indicated by arrows Fig. 3B), which are directly connected with the hydrophobic 
transmembrane part (TM helix 6 and 7, Fig. 3A) were removed from the coding sequence 
using PCR reaction (construct 3). Additionally two constructs of the MNK P-domain were 
created; first, by elongation of the C-terminus and thus ―fusion‖ of two separated (by N-
domain) parts of the P-domain sequence (construct 4), and second using the same approach 
but separating the sequence of the P-domain with two alanine residues (construct 5). 
Finally two other P-domain constructs (6 and 7) were created by eliminating the α-helices 
from the C- and N-terminal part of construct 4 and 5 sequences (Fig. 4). 
 
 
 
 
 
Figure 4. Schematic representation of the cloning process performed in order to obtain new 
constructs of Menkes ATP- and P-domains. Numbers in brackets correspond to the constructs 
described in material and methods and text.  
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Constructs 3, 5, 6 and 7 were amplified using PCR and inserted into the Gateway® 
pEntr-TEV-d-Topo vector (Invitrogen
TM
). After recombination with several destination 
vectors and subsequent transformation into E.coli host strains the expression and solubility 
test was performed using the high throughput approach. Cells were grown in the 24-well 
plates containing LB medium in presence of appropriate antibiotics at 37° C. After 
induction with 0.5 mM IPTG, plates were further incubated at different temperatures (17, 
25 or 37°C). After 5 (37°C) to 16 h (17 and 25°C) cells were pelleted by centrifugation and 
resuspended in lysis buffer (A) (50 mM Tris-Hcl, 500 mM NaCl, 5 mM imidazole) 
containing lysozyme and DNA-se I. After subsequent sonication the insoluble fraction was  
separated from the soluble fraction by centrifugation.  The applied HisTag (present in all 
the constructs) allowed purifying the expressed proteins by affinity to nickel charged 
agarose beads. The obtained supernatant was incubated with affinity agarose beads for 1 h 
at 25° C. In order to separate the beads from the cell extract, the whole samples were 
transferred into a large pore 96-well filter plate that retains the beads with bound proteins. 
The beads were washed (buffer A) and subsequently the target proteins were eluted from 
the beads, and analyzed by SDS-PAGE electrophoresis (Fig. 5). Tested conditions are 
listed in table 2.  
 
 
Table 2. Conditions tested during the expression test. Cells: G - BL21 (DE3) gold; P - (DE3) 
pLysS; R - Rosetta-2 (DE3).  
 
Construct Plasmid Cells Temperature Expected MW (kDa) 
  pDEST 17 G, P, R 17, 25, 37°C 35 
(3) ATP - H pETG 20 G, P, R 17, 25, 37°C 47 
  pETG 30 G, P, R 17, 25, 37°C 61 
  pDEST 17 G, P, R 17, 25, 37°C 20 
(5) P-dom Ala pETG 20 G, P, R 17, 25, 37°C 32 
  pETG 30 G, P, R 17, 25, 37°C 46 
  pDEST 17 G, P, R 17, 25, 37°C 17 
(6) P-dom -H pETG 20 G, P, R 17, 25, 37°C 29 
  pETG 30 G, P, R 17, 25, 37°C 43 
  pDEST 17 G, P, R 17, 25, 37°C 17 
(7) P-dom Ala -H pETG 20 G, P, R 17, 25, 37°C 29 
  pETG 30 G, P, R 17, 25, 37°C 43 
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Figure 5. SDS-PAGE electrophoresis performed after expression/solubility test. Positive results for 
each construct are marked with red circle. 
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Several positive results were obtained for each construct (Fig. 5). Conditions in which 
proteins were overexpressed and soluble had been scaled up. Recombinant proteins were 
purified by affinity chromatography employing the HisTag present in all the fusions. 
Subsequent concentration was followed by digestion with TEV protease. In all the cases 
the cleavage efficiency was not higher than 5 – 10% (judged from SDS-PAGE). Addition 
of either L-Arginine, 10% glycerol or 0.1% Tween 80 to the purified proteins as well as 
purification in presence of detergents (Tween 80, TritonX 100) did not increase the 
cleavage efficiency. The same behaviour was observed for the P-domain (construct 4). 
Samples run on the analytical gel filtration column (G2000 SWXL) were eluted in the void 
volume indicating the presence of high molecular weight aggregates (> 150kDa) (Fig. 6).  
 
 
 
Figure 6. Analytical gel filtration elution profile for MNK ATP-binding domain without helices 
(construct 3) fused with GST, purified in absence (red trace) and presence (blue trace) of 1% Tween 
80. Similar results were obtained for other constructs. 
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Light scattering experiments performed in the same conditions confirmed that the 
overexpressed proteins form soluble aggregates (Fig. 7) 
 
 
 
Figure 7. Light scattering experiments performed on the MNK ATP-binding domain without 
helices (construct 3) fused with GST, purified in absence (red trace) and presence (blue trace) of 
0.1% Tween 80. High molecular weight soluble aggregates are formed; MW of the samples 
prepared in absence (red trace) and in presence (blue trace) of detergent was estimated to 4.013 
MDa and 2.05 MDa, respectively. The expected MW of the monomeric protein fused with GST is  
61 kDa.   
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The copper ion translocation cycle performed by WLN and MNK protein involves 
several stages in which ATP hydrolysis drives translocation of the target ion across cellular 
membranes. The first step is the binding of copper to the conserved CPC motif in the 
transmembrane part of the protein, and binding of ATP to the nucleotide-binding N-
domain. ATP hydrolysis and phosphorylation of the P-domain, lead to conformational 
changes and translocation of the target ion. Finally dephosphorylation of the P-domain by 
the actuator A-domain allows restarting the cycle. Several mutations causing Menkes 
syndrome and Wilson disease are found in ATP-binding domain and are correlated with 
malfunctions of ATP binding (N-domain) or acylphosphate intermediate formation (P-
domain). At present, not all the molecular events of each domain of ATP7A and ATP7B in 
the catalytic cycle are clear. Structural and functional characterization (of wild type and 
mutated) domains will be required for understanding pathogenesis of Wilson and Menkes 
diseases.  
 Numerous variations on several different levels of protein production (e.g. cloning, 
expression and purification) were performed in order to recombinantly express the pure, 
soluble monomeric ATP-binding domain of MNK and WLN and P-domain of MNK 
proteins. However, none of these variations was sufficient to avoid protein aggregation 
either during protein synthesis or purification.  
 The obtained results for MNK and WND ATP-binding and P-domain clearly 
suggest that a different approach for construct building and protein expression is necessary 
to obtain not aggregated protein. The expression of a protein as inclusion bodies or 
presence of high molecular aggregates indicates that the protein is not folded properly. 
Wilson and Menkes proteins are composed of several soluble domains and transmembrane 
channel, it is probable that the correct folding of the ATP-binding and P-domain requires a 
presence of other subdomain/s (e.g. A-domain). The specific interactions between 
subdomains could lead to their correct folding.   
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Genome sequencing projects have provided unprecedented number of molecular 
information that promises to revolutionize our understanding of life and lead to new 
treatments of its disorders. However, genome sequences alone offer only limited insights 
into the biochemical pathways that determine protein, cell and tissue function. The vast 
number of uncharacterized proteins suggests that our knowledge of cellular biochemistry is 
far from complete. Therefore, it is clear that an integrated approach in the study is 
essential, in order to obtain information about the protein function. Indeed a large number 
of different scientific fields like bioinformatics, biochemistry, molecular and cell biology 
are necessary to fully understand the cellular pathways of life.  
My research was focused on cloning, expression and characterization of human 
proteins involved in i) Fe-S cluster biosynthesis and ii) copper homeostasis.   
We demonstrated that CIAPIN1 (anamorsin), a protein connected with apoptosis 
processes and ISC assembly in cytosol coordinates a [2Fe-2S] cluster itself, and that could 
be trapped in IMS through an interaction with Mia40, a component of disulfide relay 
system of the mitochondrial IMS. Specific incorporation of two disulfide bridges 
performed by Mia40 is independent of the cluster binding ability of anamorsin. Therefore, 
IMS localized anamorsin could be the connecting component of mitochondrial and 
cytosolic Fe-S cluster assembly machineries. Since another essential component of the 
disulfide relay system is the sulfhydryl oxidase ALR, which is as well necessary for 
cytosolic Fe-S cluster biogenesis, CIAPIN1 could be a link between ISC biogenesis and 
the disulfide relay system of the IMS. The next step in this project will be focused on the 
characterization of interaction, at the molecular level, between anamorsin and ALR and 
recently identified protein Ndor1 involved in cytosolic ISC assembly process 
Glutaredoxin 5 is a member of mitochondrial Fe-S cluster assembly machinery that 
functions in the cluster delivery to the apo-proteins. Our data showed that the protein 
coordinates a [2Fe-2S] cluster in the glutathione dependent fashion as a monomer. Basing 
on experimental results we proposed a model in which the cluster is coordinated by two 
conserved cysteines and two GSH molecules. The protein is now being structurally 
characterized and the characterization of the interaction with a putative protein partners 
ISCA1 and ISCA2 is in progress. 
In the last part of this PhD thesis I described the trials that I have performed in order to 
obtain ATP-binding and P- domain of Wilson and Menkes proteins. Numerous variations 
on several different levels of protein production (e.g. cloning, expression and purification) 
were performed. However, none of these variations was sufficient to avoid protein 
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aggregation either during protein synthesis or purification. The aggregation of proteins 
strongly suggests that they are not properly folded. The most plausible solution could be 
the expression of full length proteins, this would indeed allow the intramolecular 
interactions between the sub-domains which are probably essential, on the basis of our 
results, for the correct folding of the ATP-binding and P- domains. 
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